Processing 00000000.tx.1: Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway Terence Kin-Wah Lee1, Kwan Man1, Ming-Tat Ling2, Xiang-Hong Wang2, Yong-Chuan Wong2, Chung-Mau Lo1, Ronnie Tung-Ping Poon1, Irene Oi-Lin Ng3 and Sheung-Tat Fan1,4 Centre for the Study of Liver Disease and 1 Department of Surgery, 2 Department of Anatomy and 3 Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong, China  Abstract Top Abstract Introduction Materials and methods Results Discussion References  Inhibitors of differentiation and DNA binding-1 (Id-1) have been demonstrated to oppose Ets-mediated activation of p16INK4a. 

Phrase: "Over-expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell proliferation in hepatocellular carcinoma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0596290:Cell Proliferation [Cell Function]
   797   C1518174:Carcinoma Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1514485:Proliferation [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "through inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16INK4a/RB pathway Terence Kin-Wah Lee1,"

Phrase: "Kwan Man1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537562:MAN1 [Gene or Genome]

Phrase: "Ming-Tat Ling2,"

Phrase: "Xiang-Hong Wang2,"

Phrase: "Yong-Chuan Wong2,"

Phrase: "Chung-Mau Lo1,"

Phrase: "Ronnie Tung-Ping Poon1,"

Phrase: "Irene Oi-Lin Ng3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1422291:NG3 [Gene or Genome]

Phrase: "and"

Phrase: "Sheung-Tat Fan1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3147283:FAN1 [Gene or Genome]
   827   C3541309:FAN1 [Gene or Genome]

Phrase: "4 Centre for the Study of Liver Disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "1 Department of Surgery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "2 Department of Anatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "3 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587487:Pathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "The University of Hong Kong,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:Hong Kong [Geographic Area]
   861   C2987742:Hong Kong [Fish]
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "Pokfulam,"

Phrase: "Hong Kong,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019907:Hong Kong [Geographic Area]
  1000   C2987742:Hong Kong [Fish]

Phrase: "China  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitors of differentiation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "DNA binding-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "oppose"

Phrase: "Ets-mediated activation of p16INK4a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]
Processing 00000000.tx.2: As p16INK4a protein is inactivated in hepatocellular carcinoma (HCC), we aimed to investigate the role of Id-1 in regulating p16INK4a expression during the development of HCC in HCC patients and direct ectopic Id-1 introduction into the PLC/PRF/5 HCC cell line. 

Phrase: "As p16INK4a protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249880:p16INK4A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "inactivated in hepatocellular carcinoma (HCC),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   833   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   770   C0007097:Carcinoma [Neoplastic Process]
   770   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "we"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "p16INK4a expression during the development of HCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HCC patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "and"

Phrase: "direct ectopic Id-1 introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1293116:Introduction [Health Care Activity]
   804   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "into the PLC/PRF/5 HCC cell line."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0007600:Cell Line [Cell]
   818   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   818   C1518174:Carcinoma Cell [Cell]
   818   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   795   C0007097:Carcinoma [Neoplastic Process]
   795   C0007634:Cell [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   795   C2697585:Hepatocellular [Qualitative Concept]
Processing 00000000.tx.3: Sixty-two HCC samples were recruited for evaluation of Id-1 and proliferating cell nuclear antigen (PCNA) protein expression. 

Phrase: "Sixty-two HCC samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "recruited for evaluation of Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0220825:Evaluation [Functional Concept]
   753   C0600091:ID [Intellectual Product]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "proliferating cell nuclear antigen (PCNA) protein expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
Processing 00000000.tx.4: The messenger RNA (mRNA) expression of Id-1 and p16INK4a was detected by quantitative reverse transcriptionpolymerase chain reaction. 

Phrase: "The messenger RNA (mRNA) expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0040649:RNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "p16INK4a"

Phrase: "was"

Phrase: "detected by quantitative reverse transcriptionpolymerase chain reaction."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0337112:Chain [Manufactured Object]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.5: For in vitro Id-1 transfection, five Id-1 transfected clones were isolated and the effect of ectopic Id-1 introduction was investigated by 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, flow cytometry, immunostaining and western blot. 

Phrase: "For in vitro Id-1 transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "five Id-1 transfected clones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "the effect of ectopic Id-1 introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "investigated by 3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292732:investigated [Functional Concept]

Phrase: "(4,"

Phrase: "5-cimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "flow cytometry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "immunostaining"

Phrase: "and"

Phrase: "western blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.6: Our results showed that Id-1 was over-expressed in HCC specimens both at mRNA and protein levels. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "was"

Phrase: "over-expressed in HCC specimens"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   790   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   753   C0007097:Carcinoma [Neoplastic Process]
   753   C0205136:Over [Spatial Concept]
   753   C0370003:specimens [Substance]
   753   C2697585:Hepatocellular [Qualitative Concept]
   719 E C2347026:Specimen [Conceptual Entity]

Phrase: "both at mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0238767:Both [Spatial Concept]
   770   C0335218:Messenger [Professional or Occupational Group]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.7: Over-expression of Id-1 protein was correlated with PCNA (r = 0.334, P = 0.033). 

Phrase: "Over-expression of Id-1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205136:Over [Spatial Concept]

Phrase: "was"

Phrase: "correlated with PCNA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   790   C0069115:nuclear antigen [Immunologic Factor]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0007634:Cell [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1514485:Proliferating [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1707520:Correlated [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(r = 0.334,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.033"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.8: HCC samples showing low Id-1 protein expression had a lower Id-1 mRNA level (340.2 versus 1467%, P = 0.039) and higher p16INK4a expression (195 versus -78.6%, P = 0.039) than samples with high Id-1 protein expression. 

Phrase: "HCC samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "low Id-1 protein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   708   C0242972:low protein [Therapeutic or Preventive Procedure]
   708   C0748025:low protein [Finding]

Phrase: "had"

Phrase: "a lower Id-1 mRNA level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0441889:Level [Qualitative Concept]
   799   C0456079:Level [Classification]
   799   C1547707:Level [Geographic Area]
   799   C2946261:Level [Pharmacologic Substance]

Phrase: "(340.2"

Phrase: "versus"

Phrase: "1467%,"

Phrase: "P = 0.039"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "higher p16INK4a expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(195"

Phrase: "versus -"

Phrase: "78.6%,"

Phrase: "P = 0.039"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "with high Id-1 protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.9: In the PLC/PRF/5 HCC cell line study, ectopic Id-1 expression resulted in proliferation of HCC cells and an increased percentage of S phase cells and PCNA expression. 

Phrase: "In the PLC/PRF/5 HCC cell line study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557651:Study [Manufactured Object]
   793   C2603343:Study [Research Activity]

Phrase: "ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resulted in proliferation of HCC cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   778   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   762   C1518174:Carcinoma Cell [Cell]
   757   C0596290:Cell Proliferation [Cell Function]
   748   C0007097:Carcinoma [Neoplastic Process]
   748   C0007634:Cells [Cell]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1514485:Proliferation [Functional Concept]
   748   C2697585:Hepatocellular [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "an increased percentage of S phase cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PCNA expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
Processing 00000000.tx.10: The results showed that over-expression of Id-1 induces cell proliferation in HCC through inactivation of p16INK4a/retinoblastoma pathway. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that over-expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell proliferation in HCC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0596290:Cell Proliferation [Cell Function]
   797   C1518174:Carcinoma Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1514485:Proliferation [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "through inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16INK4a/retinoblastoma pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.11: In conclusion, the results provided an insight for the understanding of the role of Id-1 in functional inactivation of p16INK4a in HCC. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "an insight for the understanding of the role of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0233820:Insight [Mental Process]

Phrase: "in functional inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16INK4a"

Phrase: "in HCC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]
Processing 00000000.tx.12: Abbreviations: FBS, fetal bovine serum; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.13: HCC, hepatocellular carcinoma; 

Phrase: "HCC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "hepatocellular carcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.14: Id, inhibitors of differentiation and DNA binding; 

Phrase: "Id,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "inhibitors of differentiation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.15: mRNA, messenger RNA; 

Phrase: "mRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0335218:Messenger [Professional or Occupational Group]

Phrase: "messenger RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0335218:Messenger [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.16: MTT, 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-cimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.17: PCNA, proliferating cell nuclear antigen; 

Phrase: "PCNA,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "proliferating cell nuclear antigen"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: ";"
Processing 00000000.tx.18: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.19: RB, retinoblastoma; 

Phrase: "RB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "retinoblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.20: RTPCR, reverse transcription-polymerase chain reaction  Introduction Top Abstract Introduction Materials and methods Results Discussion References  Inhibitor of differentiation and DNA binding (Id) proteins are transcription factors that belong to a group of helixloophelix proteins lacking the DNA binding domain. 

Phrase: "RTPCR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1524075:Chain [Idea or Concept]

Phrase: "reverse transcription-polymerase chain reaction  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitor of differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   790   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "(Id) proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "belong to a group of helixloophelix proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0441835:Group A [Classification]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the DNA binding domain."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511662:DNA Binding Domain [Amino Acid Sequence]
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.21: Therefore, these proteins act as dominant inhibitors of basic helixloophelix transcription factors by forming transcriptionally inactive heterodimers. 

Phrase: "Therefore,"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "act as dominant inhibitors of basic helixloophelix transcription factors"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040649:Transcription [Genetic Function]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   742   C1527178:Basic [Functional Concept]
   742   C1527180:Dominant [Functional Concept]
   708   C1521761:Factor [Functional Concept]
   708 E C1999216:Inhibitor [Qualitative Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "by forming transcriptionally inactive heterodimers."
Processing 00000000.tx.22: Four Id genes (Id-1 through Id-4) are important for cell fate decisions of growth and differentiation. 

Phrase: "Four Id genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "(Id-1 through Id-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0309276:ID-1 [Pharmacologic Substance]
   760   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "important for cell fate decisions of growth"

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.23: Their expression is typically high in actively proliferating cells and is down-regulated as a prerequisite for exit from cell cycle and differentiation (13). 

Phrase: "Their expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "typically high in actively proliferating cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "down-regulated as a prerequisite"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0679209:prerequisite [Idea or Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "for exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "from cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.24: The Id family member Id-1 has been implicated in regulating cellular life span, immortalization and delayed senescence in mammalian cells (46). 

Phrase: "The Id family member Id-1"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   897   C0309276:ID-1 [Pharmacologic Substance]
   840   C0086282:Family member [Family Group]
   840   C1611821:Family Member [Intellectual Product]
   804   C0015576:Family [Family Group]
   804   C0600091:ID [Intellectual Product]
   804   C0680022:member [Population Group]
   804   C1704727:Family [Conceptual Entity]
   804   C2698041:Member [Professional or Occupational Group]
   733 E C0241888:Familial [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in"

Phrase: "regulating"

Phrase: "cellular life span,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0870809:life span [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "immortalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826170:Immortalization [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "delayed senescence in mammalian cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007581:Cell Senescence [Cell Function]
   760   C0231337:Senescence [Finding]
   760   C1999167:Senescence [Population Group]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.25: Over-expression of Id-1 has been reported in several types of primary tumors including breast (7), pancreatic (8), prostate (9), cervical (10) and colorectal adenocarcinoma (11). 

Phrase: "Over-expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in several types of primary tumors"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   782   C0585733:Type of Report [Intellectual Product]
           Report types
   778   C0677930:primary tumors [Neoplastic Process]
   748   C0027651:Tumors [Neoplastic Process]
   748   C0205225:Primary [Qualitative Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C0684224:Reported [Intellectual Product]
   748   C0700287:Reported [Health Care Activity]
   748   C3496591:Reported [Clinical Attribute]
   714 E C1547052:*Type [Quantitative Concept]
   714 E C1578706:Tumor [Intellectual Product]
   714 E C3273238:Report [Intellectual Product]
   714 E C3273930:Tumor [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "prostate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "cervical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027530:Cervical [Body Location or Region]
  1000   C0205064:Cervical [Spatial Concept]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "colorectal adenocarcinoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1319315:Colorectal Adenocarcinoma [Neoplastic Process]
   861   C0001418:Adenocarcinoma [Neoplastic Process]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.26: Previous findings showed that ectopic expression of Id-1 induced aggressiveness and metastasis in breast cancer cells (7), and up-regulation of Id-1 has been correlated with tumor stage in squamous cell carcinoma (12). 

Phrase: "Previous findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ectopic expression of Id-1 induced aggressiveness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1512167:Ectopic Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "metastasis in breast cancer cells"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   867   C1512505:Breast Cancer Cell [Cell]
   853   C0278488:metastatic breast cancer [Neoplastic Process]
   840   C0006142:Breast Cancer [Neoplastic Process]
   840   C0334227:cancer cells [Cell]
   840   C0678222:Breast Cancer [Neoplastic Process]
   839   C0027627:metastatic cancer [Neoplastic Process]
   839   C0346957:metastatic cancer [Neoplastic Process]
   839   C2939419:Metastatic cancer [Neoplastic Process]
   839   C2939420:metastatic cancer [Neoplastic Process]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0007634:Cells [Cell]
   804   C0998265:Cancer [Eukaryote]
   804   C1306459:Cancer [Finding]
   804   C3282337:Cells [Cell]
   790 E C0153661:thoracic cancer [Neoplastic Process]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "up-regulation of Id-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "correlated with tumor stage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1300072:Tumor stage [Clinical Attribute]
           Stage
   770   C0027651:Tumor [Neoplastic Process]
   770   C0205390:Stage [Temporal Concept]
   770   C1306673:Stage [Qualitative Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1707520:Correlated [Qualitative Concept]
   770   C3273930:Tumor [Finding]

Phrase: "in squamous cell carcinoma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007137:Squamous cell carcinoma [Neoplastic Process]
           Carcinoma, Squamous
   901   C0221910:Squamous cell [Cell]
   827   C0007097:Carcinoma [Neoplastic Process]
   827   C0007634:Cell [Cell]
   827   C1182670:Squamous [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.27: Most recently, over-expression of Id-1 protein has been correlated with patients' poor clinical outcome and mitotic index in several human cancers (10,11). 

Phrase: "Most recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "over-expression of Id-1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205136:Over [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "correlated with patients' poor clinical outcome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C1547647:Patient Outcome [Idea or Concept]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0032854:Poor [Group Attribute]
   753   C0205210:Clinical [Qualitative Concept]
   753   C0542537:Poor [Qualitative Concept]
   753   C1274040:Outcome [Functional Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C2700379:Poor [Qualitative Concept]

Phrase: "and"

Phrase: "mitotic index in several human cancers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0812425:Mitotic Index [Laboratory or Test Result]
   753   C0918012:Index [Intellectual Product]
   753   C1513354:Mitotic [Qualitative Concept]
   753   C1552854:index [Idea or Concept]
   753   C1637833:% index [Quantitative Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.28: This evidence strongly supports that Id-1 plays an important role not only in tumorigenesis, but also in tumor progression. 

Phrase: "This evidence strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "not only in tumorigenesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007621:Tumorigenesis [Neoplastic Process]
   770   C0205171:Only [Quantitative Concept]
   770   C0596263:Tumorigenesis [Neoplastic Process]
   770   C1518422:Not [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also in tumor progression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
Processing 00000000.tx.29: However, Id-1 expression in hepatocellular carcinoma (HCC) has not been studied and its role remains unknown. 

Phrase: "However,"

Phrase: "Id-1 expression in hepatocellular carcinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "its role remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.30: Recently, Id-1 has been demonstrated to oppose Ets-mediated activation of p16INK4a via Ras-Raf-MEK signaling (13). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "oppose"

Phrase: "Ets-mediated activation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "via Ras-Raf-MEK signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: The p16INK4a/retinoblastoma (RB) pathway has been shown to be down-regulated in various human tumors including HCC, either through loss of p16INK4a or RB function, or through down-regulated expression of cyclin D or cdk4 (1416). 

Phrase: "The p16INK4a/retinoblastoma (RB) pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "down-regulated in various human tumors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0027651:Tumors [Neoplastic Process]
   753   C0086418:Human [Human]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "HCC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "either through loss of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "or"

Phrase: "RB function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "or through"

Phrase: "down-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "expression of cyclin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "cdk4"

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.32: Several mechanisms of inactivation of p16INK4a/RB pathway have been proposed including promoter methylation, protein sequestration and post-translational modification (17). 

Phrase: "Several mechanisms of inactivation of p16INK4a/RB pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "promoter methylation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0025723:Methylation [Molecular Function]
   861   C1159269:Methylation [Molecular Function]
   789 E C0746574:methylated [Pharmacologic Substance]

Phrase: "protein sequestration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443301:Sequestration [Functional Concept]

Phrase: "and"

Phrase: "post-translational modification"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.33: However, little is known about the direct transcriptional control of genes within the p16INK4a/RB family and their role in HCC tumorigenesis. 

Phrase: "However,"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the direct transcriptional control of genes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1158770:Transcriptional Control [Genetic Function]
   744   C0017337:Genes [Gene or Genome]
   744   C0040649:Transcriptional [Genetic Function]
           genes transcription
   744   C0205309:Known [Qualitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439851:Direct [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C1947931:Direct [Qualitative Concept]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "within the p16INK4a/RB family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "their role in HCC tumorigenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.34: Therefore, we first examined the Id-1 expression in messenger RNA (mRNA) and protein levels in HCC and then investigated whether Id-1 may play a role in regulating p16INK4a expression during the development of HCC.  

Phrase: "Therefore,"

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the Id-1 expression in messenger RNA (mRNA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0040649:RNA Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein levels in HCC"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "p16INK4a expression during the development of HCC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.35: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References  Patient samples Samples were obtained with informed consent from 10 healthy liver transplant donors and 62 patients undergoing hepatectomy for HCC from 1997 to 1999 in the Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patient samples Samples"

Phrase: "were"

Phrase: "obtained with informed consent"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   881   C0514044:Informed consent obtained [Finding]
   881   C0802641:Informed consent obtained [Clinical Attribute]
   833   C0021430:Informed Consent [Regulation or Law]
   773   C1532670:Obtaining consent [Health Care Activity]
   770   C1301820:Obtained [Functional Concept]
   770   C1511481:Consent [Functional Concept]
   770   C1522154:Informed [Qualitative Concept]
   770   C1554192:consent [Idea or Concept]
   737 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0700287:inform [Health Care Activity]
   737 E C1552002:inform [Idea or Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from 10 healthy liver transplant donors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   853   C2830120:Liver donors [Finding]
   836 E C0302512:Liver donor [Population Group]
   804   C0013018:Donors [Population Group]
   804   C1527169:Donors [Finding]
   771 E C0040288:Donor [Population Group]

Phrase: "and"

Phrase: "62 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "undergoing"

Phrase: "hepatectomy for HCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019144:Hepatectomy [Therapeutic or Preventive Procedure]

Phrase: "from 1997"

Phrase: "to 1999"

Phrase: "in the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Surgery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "University of Hong Kong Medical Centre,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   904   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0019907:Hong Kong [Geographic Area]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C2987742:Hong Kong [Fish]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]

Phrase: "Queen Mary Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Hong Kong."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019907:Hong Kong [Geographic Area]
  1000   C2987742:Hong Kong [Fish]
Processing 00000000.tx.36: Id-1 and proliferating cell nuclear antigen (PCNA) immunostaining Formalin-fixed and paraffin-embedded liver sections with a thickness of 4-m were dewaxed in xylene and graded alcohols, hydrated and washed in phosphate-buffered saline. 

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "and"

Phrase: "proliferating cell nuclear antigen"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(PCNA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: ")"

Phrase: "immunostaining Formalin-fixed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0231441:Fixed [Finding]
   827   C0443218:Fixed [Qualitative Concept]
   827   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "paraffin-embedded liver sections with a thickness of 4-m"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "dewaxed in xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "graded alcohols,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0001975:Alcohols [Organic Chemical,Pharmacologic Substance]
   827 E C0001962:ALCOHOL [Organic Chemical]
   777 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "hydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0720930:hydrated [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "washed in phosphate-buffered saline."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]
Processing 00000000.tx.37: After pre-treatment in a microwave oven [16 min in sodium citrate buffer (pH 6)], the endogenous peroxidase was inhibited by 0.3% H2O2 for 30 min, and the sections were incubated with 10% normal goat serum for 30 min. 

Phrase: "After pre-treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C2709094:pre treatment [Temporal Concept]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C2257086:PRE [Genetic Function]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "in a microwave oven"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0336756:Microwave oven [Manufactured Object]
   861   C0336755:Oven [Manufactured Object]
   861   C1706357:Oven [Medical Device]

Phrase: "[16 min in sodium citrate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "(pH 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "],"

Phrase: "the endogenous peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "inhibited by 0.3% H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0311403:Inhibited [Qualitative Concept]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with 10% normal goat serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0018019:goat [Mammal]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0439166:% normal [Quantitative Concept]
   753   C1265549:goat [Mammal]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1510458:Goat [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.38: A 1:100 diluted polyclonal antibody to Id-1 (Santa Cruz Biotechnology, Santa Cruz, CA) and PCNA (Oncogene Research Products, San Diego, CA) were applied overnight in a moist chamber at 4C. 

Phrase: "A 1"

Phrase: ":"

Phrase: "100 diluted polyclonal antibody to Id-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "and"

Phrase: "PCNA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(Oncogene Research Products,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0029005:Oncogene Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "were"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "overnight in a moist chamber"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205381:Moist [Qualitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.39: For negative control, immunohistochemistry was carried out on a HCC specimen with strong Id-1 expression after blocking the antigen-binding site of the primary antibody using corresponding blocking peptide (SC-488p, Santa Cruz Biotechnology) (Figure 1G). 

Phrase: "For negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on a HCC specimen"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   790   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   753   C0007097:Carcinoma [Neoplastic Process]
   753   C0370003:Specimen [Substance]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C2347026:Specimen [Conceptual Entity]
   753   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "with strong Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "after"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the antigen-binding site of the primary antibody"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C0221114:Antigen binding site [Immunologic Factor]
   793   C0005457:Antibody binding site [Immunologic Factor,Receptor]
   789   C0597878:antigen antibody binding [Molecular Function]
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   770   C1148575:antigen binding [Molecular Function]
   770   C2945843:Site of [Qualitative Concept]
   767   C0368675:antibody antigen [Immunologic Factor]
   767   C0449695:Primary site [Spatial Concept]
   744   C0003320:Antigen [Immunologic Factor]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "corresponding blocking peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(SC-488p,"

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "(Figure 1G"

Phrase: ")."
Processing 00000000.tx.40: A standard avidinbiotin peroxidase technique (DAKO, Carpinteria, CA) was applied. 

Phrase: "A standard avidinbiotin peroxidase technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449851:Technique [Functional Concept]
   729 E C0025664:techniques [Intellectual Product]

Phrase: "(DAKO,"

Phrase: "Carpinteria,"

Phrase: "CA)"

Phrase: "was"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.41: Briefly, biotinylated goat anti-mouse Ig or goat anti-rabbit Ig and avidinbiotin peroxidase complex were applied for 30 min each, with 15-min washes in phosphate-buffered saline. 

Phrase: "Briefly,"

Phrase: "biotinylated goat anti-mouse Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C3541296:IG [Idea or Concept]

Phrase: "or"

Phrase: "goat anti-rabbit Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C3541296:IG [Idea or Concept]

Phrase: "and"

Phrase: "avidinbiotin peroxidase complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439855:Complex [Qualitative Concept]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "applied for 30 min"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0185125:Applied [Health Care Activity]
   770   C0702093:/min [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "each,"

Phrase: "with 15-min washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441648:Wash [Activity]

Phrase: "in phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.42: The reaction was finally developed by Dako Liquid DAB+ Substrate-chromogen System (DAKO). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "finally"

Phrase: "developed by Dako Liquid DAB+ Substrate-chromogen System"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0086162:Dab [Food]
   744   C0302908:Liquid [Substance]
   744   C0449913:System [Functional Concept]
   744   C1081457:dab [Fish]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1553451:System [Manufactured Object]
   744   C1561501:Liquid NOS [Substance]
   744   C1704459:System [Medical Device]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "(DAKO"

Phrase: ")."
Processing 00000000.tx.43: View larger version (130K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(130K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.44: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.45: Expression of Id-1 in normal liver, non-tumor liver and HCC. 

Phrase: "Expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in normal liver,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0577059:normal liver [Finding]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   861   C2347086:% Normal [Quantitative Concept]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "non-tumor liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0023903:TUMOR LIVER [Neoplastic Process]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "HCC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]
Processing 00000000.tx.46: Immunostaining analysis showing no Id-1 expression in (A) normal liver, weak Id-1 expression in (B) non-tumorous liver. 

Phrase: "Immunostaining analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no Id-1 expression in (A) normal liver,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   818   C0577059:normal liver [Finding]
   795   C0023884:Liver [Body Part, Organ, or Organ Component]
   795   C0205307:Normal [Qualitative Concept]
   795   C0439166:% normal [Quantitative Concept]
   795   C0736268:LIVER [Body Part, Organ, or Organ Component]
   795   C1278929:Liver [Body Part, Organ, or Organ Component]
   795   C2346688:LIVER [Food]
   795   C2347086:% Normal [Quantitative Concept]
   740 E C0205054:Hepatic [Body Location or Region]

Phrase: "weak Id-1 expression in (B) non-tumorous liver."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   791   C0023884:Liver [Body Part, Organ, or Organ Component]
   791   C0736268:LIVER [Body Part, Organ, or Organ Component]
   791   C1278929:Liver [Body Part, Organ, or Organ Component]
   791   C2346688:LIVER [Food]
   772   C0023903:TUMOR LIVER [Neoplastic Process]
   735 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.47: Differential expression of Id-1 is observed in HCC with (C) absent, (D) weak expression and (E) high expression. 

Phrase: "Differential expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "observed in HCC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   833   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   770   C0007097:Carcinoma [Neoplastic Process]
   770   C1441672:Observed [Functional Concept]
   770   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "with"

Phrase: "(C) absent,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332197:Absent [Quantitative Concept]
   861   C2699517:ABSENT [Finding]
   789 E C0424530:Absences [Finding]
   789 E C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: "D)"

Phrase: "weak expression and (E)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0004093:Weak [Sign or Symptom]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C1762617:Weak [Qualitative Concept]

Phrase: "high expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.48: Cytoplasmic Id-1 expression at the margin between non-tumor liver and HCC is shown in (F). 

Phrase: "Cytoplasmic Id-1 expression at the margin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "between non-tumor liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0023903:TUMOR LIVER [Neoplastic Process]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.49: Negative control of immunohistochemistry for Id-1 on HCC specimen with known strong Id-1 expression. 

Phrase: "Negative control of immunohistochemistry"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1639518:% negative control [Quantitative Concept]
   833   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "for Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "on HCC specimen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0370003:Specimen [Substance]
   827   C2347026:Specimen [Conceptual Entity]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "with known strong Id-1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.50: The antigen-binding site of the antibody has been blocked by a specific blocking peptide (G). 

Phrase: "The antigen-binding site of the antibody"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0221114:Antigen binding site [Immunologic Factor]
   804   C0005457:Antibody binding site [Immunologic Factor,Receptor]
   800   C0597878:antigen antibody binding [Molecular Function]
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   778   C1148575:antigen binding [Molecular Function]
   778   C2945843:Site of [Qualitative Concept]
   774   C0368675:antibody antigen [Immunologic Factor]
   748   C0003320:Antigen [Immunologic Factor]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "blocked by a specific blocking peptide"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0028778:Blocked [Pathologic Function]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0205369:Specific [Qualitative Concept]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocked [Functional Concept]
           Blocking
   753   C1552740:specific [Intellectual Product]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.51: HCC specimens with absent expression of Id-1 with strong Id-1 expression in tumor vascular endothelia (arrows) (H) (x200 magnification).  

Phrase: "HCC specimens with absent expression of Id-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0370003:specimens [Substance]
   708 E C2347026:Specimen [Conceptual Entity]

Phrase: "with strong Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in tumor vascular endothelia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0014261:Endothelium, Vascular [Tissue]
   856 E C1706972:Blood Vessel Endothelium [Tissue]
   793   C0014257:Endothelium [Tissue]
   706   C0282607:tumor blood vessel [Neoplastic Process]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "(H) (x200 magnification"

Phrase: ")."
Processing 00000000.tx.52: Cytoplasmic expression of Id-1 and nuclear staining of PCNA were determined by two independent observers who assessed semi-quantitatively the percentage of stained tumor cells as well as staining intensity. 

Phrase: "Cytoplasmic expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nuclear staining of PCNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "were"

Phrase: "determined by two independent observers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0085862:Independent [Idea or Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0870992:observers [Professional or Occupational Group]
   760   C1299583:Independent [Finding]

Phrase: "who"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "semi-quantitatively"

Phrase: "the percentage of stained tumor cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "as well as"

Phrase: "staining intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.53: The percentage of positive cells was rated as follows: 2 points, 1150% positive tumor cells; 

Phrase: "The percentage of positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "rated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871208:Rated [Activity]
   966 E C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "2 points,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "1150% positive tumor cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   875   C0439178:% positive cells [Quantitative Concept]
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.54: 3 points, 5180% positive cells; 

Phrase: "3 points,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "5180% positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.55: and 4 points, >81% positive cells. 

Phrase: "and"

Phrase: "4 points,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: ">81% positive cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.56: Staining intensity was rated as follows (18): 1 point, weak intensity; 

Phrase: "Staining intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "rated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871208:Rated [Activity]
   966 E C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "(18"

Phrase: ")"

Phrase: ":"

Phrase: "1 point,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "weak intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.57: 2 points, moderate intensity; 

Phrase: "2 points,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "moderate intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.58: and 3 points, strong intensity. 

Phrase: "and"

Phrase: "3 points,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "strong intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.59: Points for expression and percentage of positive cells were added, and specimens were attributed to four groups according to their overall scores: negative, 10% of cells stained positive, regardless of intensity; 

Phrase: "Points for expression and"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1552961:Point [Quantitative Concept]
   737   C2347617:point [Quantitative Concept]

Phrase: "percentage of positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "attributed to four groups"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0205450:Four [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "according to their overall scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Scores [Quantitative Concept]

Phrase: ":"

Phrase: "negative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "10% of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "regardless of intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.60: weak expression, 3 points; 

Phrase: "weak expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "3 points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.61: moderate expression, 45 points; 

Phrase: "moderate expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "45 points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.62: and strong expression, 67 points. 

Phrase: "and"

Phrase: "strong expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "67 points."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
Processing 00000000.tx.63: Negative to weak Id-1 expression was graded as group 1, which represented low Id-1 expression; 

Phrase: "Negative to weak Id-1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "was"

Phrase: "graded as group 1,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0441861:Group 1 [Intellectual Product]
   802   C0547053:grade 1 [Intellectual Product]
   802   C0687695:Grade 1 [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0441800:Grade [Classification]
   737   C0919553:Grade [Classification]
   737   C3244287:grade [Finding]

Phrase: "which"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "low Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.64: whereas moderate to strong Id-1 expression was graded as group 2, which represented high Id-1 expression. 

Phrase: "whereas"

Phrase: "moderate to strong Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205081:Moderate [Qualitative Concept]
   753   C1881878:Moderate [Qualitative Concept]

Phrase: "was"

Phrase: "graded as group 2,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0441865:Group 2 [Intellectual Product]
   802   C0687696:grade 2 [Intellectual Product]
   802   C1522446:Grade 2 [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0441800:Grade [Classification]
   737   C0919553:Grade [Classification]
   737   C3244287:grade [Finding]

Phrase: "which"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "high Id-1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.65: Expression of PCNA was also graded as above. 

Phrase: "Expression of PCNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "graded as above."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0441800:Grade [Classification]
   756   C0919553:Grade [Classification]
   756   C3244287:grade [Finding]
Processing 00000000.tx.66: mRNA levels of Id-1 and p16INK4a in HCC by quantitative reverse transcriptionpolymerase chain reaction (RTPCR) The liver specimen was stored at -80C until total RNA extraction. 

Phrase: "mRNA levels of Id-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p16INK4a in HCC"

Phrase: "by quantitative reverse transcriptionpolymerase chain reaction (RTPCR)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1524075:Chain [Idea or Concept]

Phrase: "The liver specimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Specimen [Substance]
   861   C2347026:Specimen [Conceptual Entity]

Phrase: "was"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C until total RNA extraction."
Processing 00000000.tx.67: The total RNA was extracted using Rneasy Midi Kit (Qiagen Company, GmbH, Germany) and the quality of the total RNA was detected by the spectrophotometer (DU-65, BECKAM, Germany). 

Phrase: "The total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Rneasy Midi Kit (Qiagen Company,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0683757:Company [Manufactured Object,Organization]

Phrase: "GmbH,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "the quality of the total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332306:Quality [Qualitative Concept]

Phrase: "was"

Phrase: "detected by the spectrophotometer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0183400:Spectrophotometer [Medical Device]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(DU-65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450385:65 [Intellectual Product]
   861   C3540681:DU [Idea or Concept]

Phrase: "BECKAM,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.68: About 0.5 g total RNA from each sample was used to perform reverse transcription reaction. 

Phrase: "About 0.5 g total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "reverse transcription reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0035380:Reverse Transcription [Genetic Function]
Processing 00000000.tx.69: Taqman Reverse Transcription Reagents (Applied Biosystem, Foster City, CA) were used according to the manufacturer's instruction (25C x 10 min, 48C x 30 min, 95C x 5 min). 

Phrase: "Taqman Reverse Transcription Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Applied Biosystem,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)"

Phrase: "were"

Phrase: "used according to the manufacturer's instruction"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0039401:Instruction [Educational Activity]
   753   C0302828:Instruction [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1273517:used [Finding]
   753   C1442085:instruction [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(25C x 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456692:/10 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "48C x 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0456693:/30 min [Temporal Concept]
   861   C1442458:30 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "95C x 5 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.70: Reverse transcription product (1 l) was used to perform real-time quantitative polymerase chain reaction (PCR) with a reaction volume of 50 l (TaqMan PCR Core Reagent Kit, Applied Biosystem) by the ABI PRISM 7700 Sequence Detection System (Applied Biosystem). 

Phrase: "Reverse transcription product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "(1 l)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "real-time quantitative polymerase chain reaction (PCR) with a reaction volume"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   837   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   820   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1550177:Real Time [Idea or Concept]
   757   C0034746:Reaction Time [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0237400:Real [Qualitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0392762:Quantitative [Quantitative Concept]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1524075:Chain [Idea or Concept]
   739   C3272377:REAL [Intellectual Product]
   739   C3541383:Time [Temporal Concept]

Phrase: "of 50 l (TaqMan PCR Core Reagent Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0812225:KIT [Medical Device]
   791   C1150635:KIT [Molecular Function]
   791   C1705212:Kit [Medical Device]
   791   C1705213:KIT [Medical Device]
   791   C3273202:Kit [Manufactured Object]

Phrase: "Applied Biosystem"

Phrase: ")"

Phrase: "by the ABI PRISM 7700 Sequence Detection System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(Applied Biosystem"

Phrase: ")."
Processing 00000000.tx.71: Probes and primers of Id-1 and p16INK4a were designed under the Primer Express software (Applied Biosystem) according to the criteria for real-time PCR. 

Phrase: "Probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "primers of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "p16INK4a"

Phrase: "were"

Phrase: "designed under the Primer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "Express"

Phrase: "software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Applied Biosystem"

Phrase: ")"

Phrase: "according to the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "for real-time PCR."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   875   C0034746:time reaction [Temporal Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.72: The sequences are listed in Table I. 

Phrase: "The sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "listed in Table I."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.73: The Taqman Ribosomal RNA Control Reagent [18S RNA probe (VIC) and primers; PE Applied Biosystem] was used for internal control in the same PCR plate well to normalize the target genes amplification copies. 

Phrase: "The Taqman Ribosomal RNA Control Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[18S RNA probe"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0035683:RNA probe [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
   734   C0035703:18S RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(VIC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0278911:VIC [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "; PE"

Phrase: "Applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "Biosystem"

Phrase: "]"

Phrase: "was"

Phrase: "used for internal control"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0597937:internal control [Mental Process]
   770   C0205102:Internal [Spatial Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1553872:Internal [Intellectual Product]
   770   C1619620:Internal [Intellectual Product]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in the same PCR plate well to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   845   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   795   C0005971:Plate [Medical Device]
   795   C0205170:Well [Qualitative Concept]
   795   C0337112:Chain [Manufactured Object]
   795   C0443286:Reaction [Functional Concept]
   795   C0445247:Same [Qualitative Concept]
   795   C1114821:Reaction [Clinical Attribute]
   795   C1139930:plate [Medical Device]
   795   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1524075:Chain [Idea or Concept]
   795   C3146287:Well [Manufactured Object]
   795   C3537155:Plate [Manufactured Object]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the target genes amplification copies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1948062:Copies [Manufactured Object]
Processing 00000000.tx.74: The PCR protocol was according to the manufacturer's recommendation [50C x 2 min, 95C x 10 min (95C x 15 s, 60C x 1 min) x50 cycles]. 

Phrase: "The PCR protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was according to the manufacturer's recommendation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0150600:Recommendation to [Health Care Activity]
   753   C0034866:Recommendation [Idea or Concept]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1421478:WAS [Gene or Genome]
   753   C1705426:Manufacturer [Population Group]

Phrase: "[50C x 2 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "95C x 10 min (95C x 15 s,"

Phrase: "60C x 1 min) x50 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1511572:Cycle [Temporal Concept]

Phrase: "]."
Processing 00000000.tx.75: All the samples were detected in triplicate and the readings from each sample and its internal control were used to calculate the gene expression level. 

Phrase: "All"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "detected in triplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the readings from each sample"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0034754:Readings [Daily or Recreational Activity]
   726 E C1705179:Reading [Finding]

Phrase: "and"

Phrase: "its internal control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0597937:internal control [Mental Process]
   861   C0205102:Internal [Spatial Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the gene expression level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C3244092:expression level [Idea or Concept]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0017262:Gene Expression [Genetic Function]
Processing 00000000.tx.76: After normalization with the internal control, the gene expression levels in HCC were calculated as the percentage of the levels in normal liver tissue and non-tumor tissue. 

Phrase: "After normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "with the internal control,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0597937:internal control [Mental Process]
   861   C0205102:Internal [Spatial Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the gene expression levels in HCC"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "calculated as the percentage of the levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0439165:Percentage [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in normal liver tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0040300:Normal Tissue [Tissue]
           Tissue
   913   C0332441:Normal tissue [Finding]
   901   C0736268:Liver tissue [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]
   734   C0577059:normal liver [Finding]

Phrase: "and"

Phrase: "non-tumor tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0475358:Tumor tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.77: View this table: [in this window] [in a new window]  Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.78: Probes and primers for quantitative RTPCR  Cell line transfection PLC/PRF/5 was obtained from the Japanese Cancer Research Bank (Tokyo, Japan). 

Phrase: "Probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for quantitative RTPCR  Cell line transfection PLC/PRF/5"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   801   C0007600:Cell Line [Cell]
   788   C0007634:Cell [Cell]
   788   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   788   C0205132:Line [Spatial Concept]
   788   C0337112:Chain [Manufactured Object]
   788   C0392762:Quantitative [Quantitative Concept]
   788   C0443286:Reaction [Functional Concept]
   788   C1114821:Reaction [Clinical Attribute]
   788   C1269647:Cell [Cell]
   788   C1524075:Chain [Idea or Concept]
   788   C1550648:Line [Substance]
   788   C1552960:Line [Quantitative Concept]
   788   C1555029:Reverse [Idea or Concept]
   788   C1704653:Cell [Medical Device]
   788   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "obtained from the Japanese Cancer Research Bank"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C1516225:Cancer Research [Research Activity]
   748   C0006826:Cancer [Neoplastic Process]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C0998265:Cancer [Eukaryote]
   748   C1301820:Obtained [Functional Concept]
   748   C1306459:Cancer [Finding]
   748   C1556094:Japanese [Population Group]
   714 E C1706701:Obtain [Activity]

Phrase: "(Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.79: The cells were transfected with 2 g of plasmid DNA of either Id-1 or pcDNA3.1() (kindly provided by Prof. Y.C.Wong of the University of Hong Kong) containing the entire coding of Id-1 or expression vector pcDNA3.1() alone using FuGENE 6 according to the manufacturer's protocol (Boehringer, Mannhein, GmbH, Germany). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 2 g of plasmid DNA of either Id-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0309276:ID-1 [Pharmacologic Substance]
   754   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   754   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0439267:g% [Quantitative Concept]
   738   C0600091:ID [Intellectual Product]

Phrase: "or"

Phrase: "pcDNA3.1"

Phrase: "("

Phrase: ")"

Phrase: "(kindly"

Phrase: "provided by Prof. Y.C.Wong"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0599518:Prof. [Professional or Occupational Group]
   753   C1999230:Provided [Activity]

Phrase: "of the University of Hong Kong"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:Hong Kong [Geographic Area]
   861   C2987742:Hong Kong [Fish]
   812   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the entire coding of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0009219:Coding [Occupational Activity]

Phrase: "or"

Phrase: "expression vector pcDNA3.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FuGENE 6 according to the manufacturer's protocol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0916399:FuGene 6 [Lipid]
           FuGene

Phrase: "(Boehringer,"

Phrase: "Mannhein,"

Phrase: "GmbH,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.80: After 48 h, the medium was replaced with fresh Dulbecco's modified Eagle minimal essential medium with Geneticin (G418) at 1 mg/ml. 

Phrase: "After 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with fresh Dulbecco's modified Eagle minimal essential medium"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   742   C0009458:Medium [Intellectual Product]
   742   C0205224:Essential [Qualitative Concept]
   742   C0325564:Eagle [Bird]
   742   C0392747:Modified [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C0443224:Fresh [Qualitative Concept]
   742   C0547040:Minimal [Qualitative Concept]
   742   C0559956:Replaced [Functional Concept]
   742   C1299987:replaced [Functional Concept]
   742   C1524031:MINIMAL [Qualitative Concept]
   742   C1551720:Eagle [Population Group]
   742   C1705217:Medium [Substance]
   742   C2827486:Fresh [Body Substance]
   742   C2945599:Minimal [Qualitative Concept]
   742   C3244283:medium [Intellectual Product]
   708 E C1554078:Replace [Idea or Concept]

Phrase: "with Geneticin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119053:Geneticin [Organic Chemical,Pharmacologic Substance]

Phrase: "(G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "at 1 mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.81: After 2 weeks of clonal selection, all the clones were grown in the presence of G418 at 0.4 mg/ml to ensure stable transfection. 

Phrase: "After 2 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of clonal selection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "all"

Phrase: "the clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "grown in the presence of G418"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0052009:G418 [Antibiotic,Organic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at 0.4 mg/ml to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439294:mg ml [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "stable transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.82: Isolated clones were expanded to 25 cm2 flasks. 

Phrase: "Isolated clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "expanded to 25 cm2 flasks."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205229:expanded [Spatial Concept]
   760   C0439479:cm2 [Quantitative Concept]
   760   C0555206:CM2 [Congenital Abnormality]
   760   C0872171:flasks [Medical Device]
Processing 00000000.tx.83: All the transfected cells used in this experiment were in early passages (passages 48). 

Phrase: "All"

Phrase: "the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "used in this experiment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were in early passages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1279919:Early [Temporal Concept]
   737   C0439799:Passage [Spatial Concept]

Phrase: "(passages 48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.84: 3-(4,5-Cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay PLC/PRF/5 were seeded into 96-well plates in medium containing 10% fetal bovine serum (FBS) and serum free medium replaced the FCS containing medium 24 h after plating. 

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-Cimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay PLC/PRF/5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2986858:MTT Assay [Research Activity]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C0647210:mtt [Lipid]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "seeded into 96-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "in medium containing 10% fetal bovine serum (FBS)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0007452:Bovine [Mammal]
   795   C0015965:Fetal [Embryonic Structure]
   795   C0229671:Serum [Body Substance]
   795   C0521457:Fetal [Functional Concept]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "serum free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "the FCS containing medium 24 h after plating."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.85: After 48 h, MTT dye, at a concentration of 5 mg/ml (Sigma, St Louis, MO) was added every day and the plates were incubated for 12 h in a moist chamber at 37C. 

Phrase: "After 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "MTT dye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 5 mg/ml (Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "every day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0332173:Every day [Temporal Concept]
           /day
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
   861   C1720374:Every [Intellectual Product]
   861   C1948061:Every [Qualitative Concept]

Phrase: "and"

Phrase: "the plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated for 12 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in a moist chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "at 37C."
Processing 00000000.tx.86: Optical density was determined by eluting the dye with dimethyl sulfoxide (Sigma), and the absorbance was measured at 570 nm. 

Phrase: "Optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "determined by eluting"

Phrase: "the dye with dimethyl sulfoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 570 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.87: Three independent experiments were performed. 

Phrase: "Three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.88: Cell cycle analysis Cells (5 x 105) were trypsinized and washed once in PBS. 

Phrase: "Cell cycle analysis Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]

Phrase: "(5 x 105"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "trypsinized"

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once in PBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]
Processing 00000000.tx.89: They were then fixed in cold 70% ethanol and stored at 4C. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed in cold 70% ethanol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1381542:70% Ethanol [Clinical Drug]
   760   C0001962:Ethanol [Organic Chemical]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0231441:Fixed [Finding]
   760   C0234192:Cold [Physiologic Function]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stored at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.90: Before testing, the ethanol was removed and the cells were resuspended in PBS. 

Phrase: "Before testing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]

Phrase: "the ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:Ethanol [Organic Chemical]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.91: The fixed cells were then washed with PBS and treated with RNase (1 g/ml) and stained with propidium iodide (50 g/ml) for 30 min at 37C. 

Phrase: "The fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "treated with RNase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "stained with propidium iodide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0021966:Iodide [Inorganic Chemical]
   770   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 30 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439445:mL/min [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.92: Cell cycle analysis was performed on an EPICS profile analyzer and analyzed using the ModFit LT2.0 software (Coulter Electronics, Hialeah, FL). 

Phrase: "Cell cycle analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "was"

Phrase: "performed on an EPICS profile analyzer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0179038:Analyzer [Medical Device]
   753   C0884358:Performed [Functional Concept]
   753   C1706246:Analyzer [Manufactured Object]
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]
   719   C1273342:EPIC [Laboratory Procedure]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ModFit LT2.0 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Coulter Electronics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013850:Electronics [Manufactured Object]

Phrase: "Hialeah,"

Phrase: "FL)."
Processing 00000000.tx.93: Western blotting The cells were lysed and protein extraction was performed. 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "protein extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.94: The samples were separated in 10% sodium dodecylsulfate acrylamide gel and electrophoretically transferred to PVDF membrane (Amersham, Buckinghamshire, UK). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated in 10% sodium dodecylsulfate acrylamide gel"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   748   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "electrophoretically"

Phrase: "transferred to PVDF membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "(Amersham,"

Phrase: "Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.95: The membrane was blotted with 10% non-fat milk, washed and then probed with Id-1 (1:500, Santa Cruz Biotechnology), CDK4 (1:500, Calbiochem, La Jolla, CA), p16Ink4a (1:500, Santa Cruz Biotechnology) and pRB (1:200, Santa Cruz Biotechnology). 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "blotted with 10% non-fat milk,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0991850:fat milk [Lipid,Pharmacologic Substance]
   753   C0026131:Milk [Body Substance]
   753   C0349374:Milk [Food]
   753   C0424612:FAT [Organism Attribute]
   753   C0444318:Milk [Substance]
   753   C1518422:Non [Functional Concept]
   753   C2825079:Milk [Food]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with Id-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0309276:ID-1 [Pharmacologic Substance]
   770   C0600091:ID [Intellectual Product]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500,"

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "CDK4"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500,"

Phrase: "Calbiochem,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA),"

Phrase: "p16Ink4a"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500,"

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "pRB (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080113:pRb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "200,"

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.96: After washing, the membrane was then incubated with horseradish peroxidase-conjugated rabbit anti-mouse antibody (Amersham) and then visualized by enhanced chemiluminescense plus according to the manufacturer's protocol. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with horseradish peroxidase-conjugated rabbit anti-mouse antibody"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0034493:Rabbit [Mammal]
   742   C0330510:Horseradish [Food]
   742   C0522529:Conjugated [Spatial Concept]
   742   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   742   C1110641:Horseradish [Plant]
   742   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   742   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Amersham"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "visualized by enhanced chemiluminescense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0234621:Visualized [Functional Concept]
   770   C2349975:Enhanced [Activity]

Phrase: "plus according to the manufacturer's protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332287:Plus [Qualitative Concept]
Processing 00000000.tx.97: Statistical analysis Continuous variables were expressed as median and range. 

Phrase: "Statistical analysis Continuous variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439828:variables [Qualitative Concept]

Phrase: "were"

Phrase: "expressed as median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0549183:Median [Spatial Concept]
   790   C0876920:Median [Quantitative Concept]
   790   C2347635:Median [Quantitative Concept]
   790   C2348144:Median [Quantitative Concept]
   790   C2939193:Median [Spatial Concept]

Phrase: "and"

Phrase: "range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]
Processing 00000000.tx.98: The Mann Whitney U test was used for statistical comparison. 

Phrase: "The Mann Whitney U test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used for statistical comparison."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0038215:Statistical [Occupation or Discipline]
   770   C1273517:used [Finding]
   770   C1707455:Comparison [Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.99: The Pearson test was used for bivariate correlation comparison. 

Phrase: "The Pearson test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used for bivariate correlation comparison."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C1273517:used [Finding]
   760   C1707455:Comparison [Activity]
   760   C1707520:Correlation [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.100: Significance was defined as P < 0.05. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "defined as P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.101: Calculations were made with the help of SPSS computer software (SPSS, Chicago, IL).  

Phrase: "Calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "made with the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881534:Make [Functional Concept]

Phrase: "help of SPSS computer software"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0037585:Computer software [Intellectual Product,Manufactured Object]
           Software
   760   C0009622:Computer [Manufactured Object]
   760   C0018896:Help [Social Behavior]
   760   C1552861:help [Idea or Concept]

Phrase: "(SPSS,"

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.102: Results Top Abstract Introduction Materials and methods Results Discussion References  Expression of Id-1 protein in normal, non-tumor and tumor tissue from human HCC by immunostaining In order to determine the significance of Id-1 expression in HCC, we evaluated 62 samples of HCC and their corresponding non-tumor tissues by immunostaining. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of Id-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in normal, non-tumor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027651:Tumor [Neoplastic Process]
   827   C1518422:Non [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "tumor tissue from human HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0475358:Tumor tissue [Tissue]
   783   C0440744:Human tissue [Tissue]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "by immunostaining"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "the significance of Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "in HCC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "62 samples of HCC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "their corresponding non-tumor tissues by immunostaining."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0475358:tissues tumor [Tissue]
   748   C0040300:Tissues [Tissue]
   714 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.103: In normal liver, no cytoplasmic expression of Id-1 in hepatocytes was observed (Figure 1A). 

Phrase: "In normal liver,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0577059:normal liver [Finding]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   861   C2347086:% Normal [Quantitative Concept]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "no cytoplasmic expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.104: However, in non-tumor liver (cirrhotic liver or chronic hepatitis), absent to weak cytoplasmic expression of Id-1 was observed (Figure 1B). 

Phrase: "However,"

Phrase: "in non-tumor liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0023903:TUMOR LIVER [Neoplastic Process]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "(cirrhotic liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0439686:Cirrhotic [Qualitative Concept]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "or"

Phrase: "chronic hepatitis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0019189:Hepatitis, Chronic [Disease or Syndrome]
   861   C0019158:Hepatitis [Disease or Syndrome]
   861   C0019159:hepatitis [Disease or Syndrome]
   861   C0205191:chronic [Temporal Concept]
   861   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "absent to weak cytoplasmic expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:Absent [Quantitative Concept]
   744   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: In HCC samples, cytoplasmic expression of Id-1 was not found in eight cases (12.9%) (Figure 1C), weak in 16 cases (25.8%) (Figure 1D), moderate in 25 cases (40.3%), and strong in 13 cases (20%) (Figure 1E). 

Phrase: "In HCC samples,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "cytoplasmic expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found in eight cases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0205454:Eight [Quantitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(12.9%"

Phrase: ")"

Phrase: "(Figure 1C"

Phrase: ")"

Phrase: ","

Phrase: "weak in 16 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004093:Weak [Sign or Symptom]
   770   C1762617:Weak [Qualitative Concept]

Phrase: "(25.8%"

Phrase: ")"

Phrase: "(Figure"

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "moderate in 25 cases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205081:Moderate [Qualitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1881878:Moderate [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   715 E C1553901:Mitigate [Idea or Concept]

Phrase: "(40.3%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "strong in 13 cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442821:Strong [Qualitative Concept]

Phrase: "(20%"

Phrase: ")"

Phrase: "(Figure 1E"

Phrase: ")."
Processing 00000000.tx.106: The margin between non-tumor liver and tumor was shown in Figure 1F. 

Phrase: "The margin between non-tumor liver"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C2329884:Hepatic margin [Body Location or Region]
   753   C0205284:Margin [Spatial Concept]
   753   C0229985:margin [Body Part, Organ, or Organ Component]
   753   C1269830:Margin [Finding]

Phrase: "and"

Phrase: "tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027651:Tumor [Neoplastic Process]
  1000   C1578706:Tumor [Intellectual Product]
  1000   C3273930:Tumor [Finding]

Phrase: "was"

Phrase: "shown in Figure 1F."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.107: Twenty-four cases were graded as group 1, which represented low Id-1 expression, whereas 38 cases were graded as group 2, which represented high Id-1 expression. 

Phrase: "Twenty-four cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "graded as group 1,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0441861:Group 1 [Intellectual Product]
   802   C0547053:grade 1 [Intellectual Product]
   802   C0687695:Grade 1 [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0441800:Grade [Classification]
   737   C0919553:Grade [Classification]
   737   C3244287:grade [Finding]

Phrase: "which"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "low Id-1 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "38 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "graded as group 2,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0441865:Group 2 [Intellectual Product]
   802   C0687696:grade 2 [Intellectual Product]
   802   C1522446:Grade 2 [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0441800:Grade [Classification]
   737   C0919553:Grade [Classification]
   737   C3244287:grade [Finding]

Phrase: "which"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "high Id-1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.108: mRNA levels of Id-1 and p16INK4a in normal, non-tumor and tumor tissues by quantitative RTPCR The mRNA level of Id-1 and its correlation to p16INK4a were examined by quantitative RTPCR. 

Phrase: "mRNA levels of Id-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p16INK4a in normal, non-tumor"

Phrase: "and"

Phrase: "tumor tissues by quantitative RTPCR"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0475358:tissues tumor [Tissue]
   744   C0040300:Tissues [Tissue]
   711 E C1547928:Tissue [Intellectual Product]

Phrase: "The mRNA level of Id-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its correlation to p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "examined by quantitative RTPCR."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0332128:Examined [Finding]
   748   C0337112:Chain [Manufactured Object]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.109: The Id-1mRNA expression in non-tumor and tumor tissues showed higher levels when compared with the normal liver from healthy liver transplant donors. 

Phrase: "The Id-1mRNA expression in non-tumor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tumor tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0475358:Tumor tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "higher levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with the normal liver"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0577059:normal liver [Finding]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]
   760   C2346688:LIVER [Food]
   760   C2347086:% Normal [Quantitative Concept]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "from healthy liver transplant donors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C2830120:Liver donors [Finding]
   858 E C0302512:Liver donor [Population Group]
   812   C0013018:Donors [Population Group]
   812   C1527169:Donors [Finding]
   779 E C0040288:Donor [Population Group]
Processing 00000000.tx.110: For non-tumor liver, the median level was 192% (range 12.8562%) of normal liver level (100%). 

Phrase: "For non-tumor liver,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0023903:TUMOR LIVER [Neoplastic Process]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "the median level"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C0549183:Median [Spatial Concept]
   861   C0876920:Median [Quantitative Concept]
   861   C1547707:Level [Geographic Area]
   861   C2347635:Median [Quantitative Concept]
   861   C2348144:Median [Quantitative Concept]
   861   C2939193:Median [Spatial Concept]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "192%"

Phrase: "(range 12.8562%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "of normal liver level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0577059:normal liver [Finding]

Phrase: "(100%"

Phrase: ")."
Processing 00000000.tx.111: There was no significant difference in Id-1 at mRNA level in non-tumor liver between groups 1 and 2 [182.3 (12.8473%) versus 198.7% (74.2562%); P = 0.78]. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "at mRNA level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in non-tumor liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0023903:TUMOR LIVER [Neoplastic Process]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "between groups 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[182.3"

Phrase: "(12.8473%"

Phrase: ")"

Phrase: "versus"

Phrase: "198.7%"

Phrase: "(74.2562%"

Phrase: ")"

Phrase: "; P = 0.78"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.112: There was significant difference in Id-1 at mRNA level in tumors between group 1 and group 2 [260 (-828171) versus 1467% (1417313%); P = 0.022] (Figure 2A). 

Phrase: "There"

Phrase: "was"

Phrase: "significant difference in Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "at mRNA level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "between group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "[260"

Phrase: "(-828171"

Phrase: ")"

Phrase: "versus"

Phrase: "1467%"

Phrase: "(1417313%"

Phrase: ")"

Phrase: "; P = 0.022"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450305:0.022" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]"

Phrase: "(Figure 2A"

Phrase: ")."
Processing 00000000.tx.113: As for the mRNA levels of p16INK4a, there was significantly less expression in patients of group 2 than patients of group 1 [194 (-99.946480%) versus -78.6 (-98.964.28%); P = 0.039)] (Figure 2B). 

Phrase: "As for the mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of p16INK4a,"

Phrase: "there"

Phrase: "was"

Phrase: "significantly less expression in patients of group 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "than patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "of group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "[194"

Phrase: "(-99.946480%"

Phrase: ")"

Phrase: "versus -"

Phrase: "78.6"

Phrase: "(-98.964.28%"

Phrase: ")"

Phrase: "; P = 0.039"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "]"

Phrase: "(Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.114: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.115: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.116: Id-1 mRNA level in HCC relative to non-tumor in group 1 (n = 24) and group 2 (n = 38) is shown in (A) while p16INK4a mRNA level in HCC relative to non-tumor liver in group 1 and group 2 is shown in (B).  

Phrase: "Id-1 mRNA level in HCC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "relative to non-tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "in group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(n = 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(n = 38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (A)"

Phrase: "while"

Phrase: "p16INK4a mRNA level in HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "relative to non-tumor liver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "in group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (B"

Phrase: ")."
Processing 00000000.tx.117: Correlation of Id-1 and PCNA in HCC tissues Id-1 was suggested to play an important role in proliferation. 

Phrase: "Correlation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "PCNA in HCC tissues Id-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   760   C0069115:nuclear antigen [Immunologic Factor]
   757   C1518174:Carcinoma Cell [Cell]
   739   C0003320:Antigen [Immunologic Factor]
   739   C0007634:Cell [Cell]
   739   C0521447:Nuclear [Spatial Concept]
   739   C1269647:Cell [Cell]
   739   C1514485:Proliferating [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.118: To determine whether over-expression of Id-1 will be correlated with increased proliferation in HCC, we evaluated the expression of Id-1 and a proliferative marker PCNA by immunostaining. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "over-expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "will"

Phrase: "be"

Phrase: "correlated with increased proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C0442805:Increased [Functional Concept]
   770   C1514485:Proliferation [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in HCC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a proliferative marker PCNA by immunostaining."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   764   C0069115:nuclear antigen [Immunologic Factor]
   762   C0348042:A antigen [Immunologic Factor]
   742   C0003320:Antigen [Immunologic Factor]
   742   C0007634:Cell [Cell]
   742   C0521447:Nuclear [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1514485:Proliferating [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.119: All cases showed PCNA immunoreactivity in which it was strong in nine cases (15%), moderate in 31 cases (50%) and weak in 22 cases (35%). 

Phrase: "All cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "PCNA immunoreactivity in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "it"

Phrase: "was"

Phrase: "strong in nine cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442821:Strong [Qualitative Concept]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "moderate in 31 cases"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205081:Moderate [Qualitative Concept]
   770   C0450355:31 [Intellectual Product]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1881878:Moderate [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   715 E C1553901:Mitigate [Idea or Concept]

Phrase: "(50%"

Phrase: ")"

Phrase: "and"

Phrase: "weak in 22 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004093:Weak [Sign or Symptom]
   770   C1762617:Weak [Qualitative Concept]

Phrase: "(35%"

Phrase: ")."
Processing 00000000.tx.120: Id-1 protein was found to significantly and positively correlate with PCNA expression (r = 0.334, P = 0.033) (Figure 3A and B). 

Phrase: "Id-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "and"

Phrase: "positively"

Phrase: "correlate with PCNA expression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   778   C0069115:nuclear antigen [Immunologic Factor]
   748   C0003320:Antigen [Immunologic Factor]
   748   C0007634:Cell [Cell]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1514485:Proliferating [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(r = 0.334,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.033"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.121: View larger version (160K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(160K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.123: Expression of Id-1 and PCNA in samples of HCC patients and PLC/PRF/5 harboring empty vector and Id-1 transfectants. 

Phrase: "Expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PCNA in samples of HCC patients"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   760   C0069115:nuclear antigen [Immunologic Factor]
   757   C1518174:Carcinoma Cell [Cell]
   739   C0003320:Antigen [Immunologic Factor]
   739   C0007634:Cell [Cell]
   739   C0521447:Nuclear [Spatial Concept]
   739   C1269647:Cell [Cell]
   739   C1514485:Proliferating [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PLC/PRF/5"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "and"

Phrase: "Id-1 transfectants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]
Processing 00000000.tx.124: Some HCC specimens show strong cytoplasmic expression of Id-1 (A), and also strongly positive for PCNA (B) in the same specimens. 

Phrase: "Some HCC specimens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "strong cytoplasmic expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also strongly positive for PCNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0439178:positive cell [Quantitative Concept]
           % Positive
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C2825490:Positive [Qualitative Concept]

Phrase: "(B) in the same specimens."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.125: Id-1 expression is positively correlated with PCNA (r = 0.334, P = 0.033) (x200 magnification). 

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "is"

Phrase: "positively"

Phrase: "correlated with PCNA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   790   C0069115:nuclear antigen [Immunologic Factor]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0007634:Cell [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1514485:Proliferating [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1707520:Correlated [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(r = 0.334,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.033"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(x200 magnification"

Phrase: ")."
Processing 00000000.tx.126: In in vitro cell culture model, strong Id-1 expression is observed in (C) Id-1 transfectant (clone 3) when compared with (D) PLC/PRF/5 harboring empty vector. 

Phrase: "In in vitro cell culture model,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   911   C1515654:In Vitro Model [Research Activity]
   840   C0007585:Cell Culture [Laboratory Procedure]
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   804   C0007634:Cell [Cell]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2242979:Culture [Laboratory Procedure]
   804   C3161035:Model [Intellectual Product]

Phrase: "strong Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in (C) Id-1 transfectant"

Phrase: "(clone 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "when"

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "("

Phrase: "D)"

Phrase: "PLC/PRF/5"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.127: Increased PCNA expression is also observed in (E) Id-1 transfectant (clone 3) when compared with (F) PLC/PRF/5 harboring empty vector.  

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "PCNA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in (E)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0150312:In [Quantitative Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0332285:In [Spatial Concept]

Phrase: "Id-1 transfectant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "(clone 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "when"

Phrase: "compared with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Compared [Activity]

Phrase: "(F) PLC/PRF/5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.128: Correlation of Id-1 and PCNA in HCC cell line The effect of Id-1 expression in proliferation was also studied by directly transfecting Id-1 or pCDNA3.1 into PLC/PRF/5. 

Phrase: "Correlation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "PCNA in HCC cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   764   C0069115:nuclear antigen [Immunologic Factor]
   762   C0007600:Cell Line [Cell]
   762   C1518174:Carcinoma Cell [Cell]
   742   C0003320:Antigen [Immunologic Factor]
   742   C0007634:Cell [Cell]
   742   C0521447:Nuclear [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1514485:Proliferating [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "The effect of Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "studied by directly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1947931:Directly [Qualitative Concept]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "transfecting"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "or"

Phrase: "pCDNA3.1 into PLC/PRF/5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C1538187:PRF-1 [Gene or Genome]
Processing 00000000.tx.129: After clonal selection, five clones were isolated. 

Phrase: "After clonal selection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "five clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "isolated."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.130: From the in vitro result, clone 3 showed high Id-1 expression when compared with PLC/PRF/5 harboring empty vector (Figure 3C and D). 

Phrase: "From the in vitro result,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "clone 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "high Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "compared with PLC/PRF/5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "(Figure 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.131: Clone 3 showed increased PCNA expression when compared with PLC/PRF/5 harboring empty vector (Figure 3E and F). 

Phrase: "Clone 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increased PCNA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]

Phrase: "when"

Phrase: "compared with PLC/PRF/5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "(Figure 3E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.132: The effect of ectopic Id-1 introduction on HCC cell growth The effect of FBS on Id-1 expression in PLC/PRF/5 was shown in western blot. 

Phrase: "The effect of ectopic Id-1 introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on HCC cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007595:Cell Growth [Cell Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]

Phrase: "The effect of FBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "in PLC/PRF/5"

Phrase: "was"

Phrase: "shown in western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.133: In the absence of FBS in the culture medium, the level of Id-1 protein was barely detectable when compared with the presence of FBS in the culture medium (Figure 4A). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of FBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "in the culture medium,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "the level of Id-1 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0428479:Protein level [Laboratory or Test Result]
   783   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "barely detectable"

Phrase: "when"

Phrase: "compared with the presence of FBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0007452:Bovine [Mammal]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0229671:Serum [Body Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0521457:Fetal [Functional Concept]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1707455:Compared [Activity]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.134: As shown in Figure 4A, in the absence of FBS, all 5 clones showed different levels of Id-1 expression. 

Phrase: "As"

Phrase: "shown in Figure 4A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450373:4a [Intellectual Product]
   770   C1553636:4a [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "all 5 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "different levels of Id-1 expression."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456947:Level 1 [Intellectual Product]
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.135: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 4. 

Phrase: "4."
Processing 00000000.tx.137: Assessment of Id-1, p16INK4a, CDK4, RB and -actin (for protein level reference) by western blot in Id-1 transfectants and PLC/PRF/5 harboring empty vector. 

Phrase: "Assessment of Id-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "p16INK4a,"

Phrase: "CDK4,"

Phrase: "RB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "and -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "("

Phrase: "for protein level reference"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]
   734   C0428479:Protein level [Laboratory or Test Result]

Phrase: ")"

Phrase: "by western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "in Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "and"

Phrase: "PLC/PRF/5"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.138: (A) Id-1 expression in control and Id-1 transfectants after 48 h FBS starving. 

Phrase: "(A) Id-1 expression in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Id-1 transfectants after 48 h FBS starving."
Processing 00000000.tx.139: (B) Decreased p16INK4a expression is found in Id-1 transfectants. 

Phrase: "(B) Decreased p16INK4a expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "found in Id-1 transfectants."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0309276:ID-1 [Pharmacologic Substance]
   760   C0150312:Found [Quantitative Concept]
   760   C0600091:ID [Intellectual Product]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.140: (C) Presence of CDK4 phosphorylation in Id-1 transfectants. 

Phrase: "(C) Presence of CDK4 phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in Id-1 transfectants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]
Processing 00000000.tx.141: (D) Presence of RB phosphorylation in Id-1 transfectants but not in PLC/PRF/5-harboring empty vector.  

Phrase: "("

Phrase: "D)"

Phrase: "Presence of RB phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "but"

Phrase: "not in PLC/PRF/5-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1518422:Not [Functional Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.142: After transfection of Id-1, PLC/PRF/5 exhibited a relatively different morphology with flatter structure when compared with the parental cell. 

Phrase: "After transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of Id-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "PLC/PRF/5"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a relatively different morphology with flatter structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332437:Morphology [Qualitative Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "when"

Phrase: "compared with the parental cell."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0030551:Parental [Family Group]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1707455:Compared [Activity]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: We evaluated the effect of ectopic Id-1 introduction by MTT assay. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the effect of ectopic Id-1 introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "by MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.144: Introduction of Id-1 resulted in increased cell growth when compared with the parental cell and PLC/PRF/5 harboring empty vector (Figure 5). 

Phrase: "Introduction of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "resulted in increased cell growth"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   806   C0007595:Cell Growth [Cell Function]
   797   C0333957:Increased growth [Pathologic Function]
   760   C0007634:Cell [Cell]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0205217:Increased [Quantitative Concept]
   760   C0220844:growth [Physiologic Function]
   760   C0442805:Increased [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2911660:Growth [Activity]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "when"

Phrase: "compared with the parental cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0030551:Parental [Family Group]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1707455:Compared [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PLC/PRF/5"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "(Figure 5"

Phrase: ")."
Processing 00000000.tx.145: The increase in cell growth was correlated with the level of Id-1 expression. 

Phrase: "The increase in cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007595:Cell Growth [Cell Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "correlated with the level of Id-1 expression."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0309276:ID-1 [Pharmacologic Substance]
   767   C0456947:Level 1 [Intellectual Product]
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C0600091:ID [Intellectual Product]
   744   C1547707:Level [Geographic Area]
   744   C1707520:Correlated [Qualitative Concept]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.146: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.148: Growth curves of Id-1 transfectants and pCDNA3.1 by MTT assay. 

Phrase: "Growth curves of Id-1 transfectants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "pCDNA3.1 by MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986858:MTT Assay [Research Activity]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C0647210:mtt [Lipid]
   760   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.149: Each time point was derived from three independent experiments and the error bars represented standard deviation. 

Phrase: "Each time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "derived from three independent experiments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "the error"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0743559:error [Qualitative Concept]
  1000   C1608199:Error [Functional Concept]

Phrase: "bars"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]

Phrase: "represented standard deviation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0871420:Standard deviation [Quantitative Concept]
   827   C0012727:Deviation [Spatial Concept]
   827   C0205419:Deviation [Qualitative Concept]
   827   C1442989:Standard [Qualitative Concept]
   827   C1705236:Deviation [Finding]
   827   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.150: Increased growth rate was correlated with the increased Id-1 expression.  

Phrase: "Increased growth rate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0333957:Increased growth [Pathologic Function]
   901   C0449249:Growth rate [Temporal Concept]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "correlated with the increased Id-1 expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.151: Effect of Id-1 introduction in cell cycle distribution Next, we studied if Id-1 induced cell growth was a result of its ability to initiate DNA synthesis in HCC cell line in FBS free medium. 

Phrase: "Effect of Id-1 introduction in cell cycle distribution Next,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "if"

Phrase: "Id-1 induced cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007595:Cell Growth [Cell Function]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "a result of its ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "DNA synthesis in HCC cell line"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0598312:DNA Synthesis [Genetic Function]
   778   C1328870:DNA synthesis [Laboratory Procedure]
   778   C1817262:DNA synthesis [Genetic Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C2936320:Synthetic Cell [Manufactured Object]

Phrase: "in FBS free medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0009458:Medium [Intellectual Product]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]
Processing 00000000.tx.152: Cell cycle analysis showed that there was 18% of S phase in the PLC/PRF/5 harboring pCDNA3.1 (control), but the percentage of S phase cells significantly increased (25.137%) in Id-1 transfectants. 

Phrase: "Cell cycle analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "was"

Phrase: "18% of S phase in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0080129:S Phase [Temporal Concept]
   804   C0205390:Phase [Temporal Concept]

Phrase: "the PLC/PRF/5 harboring pCDNA3.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1538187:PRF-1 [Gene or Genome]
   766   C0475311:Harbor [Manufactured Object]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the percentage of S phase cells significantly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(25.137%"

Phrase: ")"

Phrase: "in Id-1 transfectants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]
Processing 00000000.tx.153: There was no significant change in the percentage of G2 phase (Figure 6). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant change in the percentage of G2 phase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0442739:No change [Finding]
   762   C0597205:phase change [Quantitative Concept]
   762   C1548568:No change [Intellectual Product]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "(Figure 6"

Phrase: ")."
Processing 00000000.tx.154: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 6. 

Phrase: "6."
Processing 00000000.tx.156: Cell cycle distribution in cells cultured in serum-free medium for 48 h. 

Phrase: "Cell cycle distribution in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "cultured in serum-free medium"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1705217:Medium [Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.157: Significant increased cell percentages in S phase are observed in Id-1 transfected clones.  

Phrase: "Significant increased cell percentages in S phase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2963400:Cell phase [Temporal Concept]
   818   C0080129:S Phase [Temporal Concept]
   795   C0205390:Phase [Temporal Concept]

Phrase: "are"

Phrase: "observed in Id-1 transfected clones."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0009013:Clones [Cell]
   753   C0600091:ID [Intellectual Product]
   753   C1441672:Observed [Functional Concept]
   719 E C1522642:Clone [Tissue]
Processing 00000000.tx.158: Effect of Id-1 expression in p16INK4a/RB pathway We have shown that expression of Id-1 was negatively correlated with p16INK4a in HCC samples and positively correlated with increased growth in PLC/PRF/5 in cell culture. 

Phrase: "Effect of Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in p16INK4a/RB pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "negatively"

Phrase: "correlated with p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlated [Qualitative Concept]

Phrase: "in HCC samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "and"

Phrase: "positively"

Phrase: "correlated with increased growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0333957:Increased growth [Pathologic Function]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220844:growth [Physiologic Function]
   770   C0442805:Increased [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C1707520:Correlated [Qualitative Concept]
   770   C2911660:Growth [Activity]

Phrase: "in PLC/PRF/5 in cell culture."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007585:Cell Culture [Laboratory Procedure]
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.159: To examine whether the increased proliferation was through inactivation of p16INK4a/RB pathway, we evaluated the expression levels of p16INK4a, CDK4 and RB in Id-1 expressing clones and PLC/PRF/5 harboring pCDNA3.1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the increased proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "was through inactivation of p16INK4a/RB pathway,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0035335:Retinoblastoma [Neoplastic Process]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]
   748   C1421478:WAS [Gene or Genome]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the expression levels of p16INK4a,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "CDK4"

Phrase: "and"

Phrase: "RB in Id-1 expressing clones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0694889:retinoblastoma 1 [Gene or Genome]
   753   C0035335:Retinoblastoma [Neoplastic Process]
   753   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "and"

Phrase: "PLC/PRF/5 harboring pCDNA3.1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1538187:PRF-1 [Gene or Genome]
   766   C0475311:Harbor [Manufactured Object]
Processing 00000000.tx.160: As shown in Figure 4B, the level of p16INK4a was weak and barely detectable in 5 Id-1 tranfectants and was inversely proportional to ectopic Id-1 expression. 

Phrase: "As"

Phrase: "shown in Figure 4B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450375:4b [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "the level of p16INK4a"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004093:Weak [Sign or Symptom]
  1000   C1762617:Weak [Qualitative Concept]

Phrase: "and"

Phrase: "barely detectable in 5 Id-1 tranfectants"

Phrase: "and"

Phrase: "was"

Phrase: "inversely proportional to ectopic Id-1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.161: This in vitro result confirmed our data from the clinical samples that over-expression of Id-1 correlated with decreased p16INK4a expression. 

Phrase: "This in vitro result"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "our data from the clinical samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1516606:Clinical Data [Intellectual Product]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "that over-expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "correlated with decreased p16INK4a expression."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1707520:Correlated [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.162: The phosphorylated form of CDK4 (upper band in Figure 4C) was also found in all five Id-1 transfectants and parental cells in the presence of FBS in the culture medium, but not in parental cells in the absence of FBS in the culture medium. 

Phrase: "The phosphorylated form of CDK4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "(upper band in Figure 4C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "found in all five Id-1 transfectants"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0150312:Found [Quantitative Concept]
   748   C0205451:Five [Quantitative Concept]
   748   C0600091:ID [Intellectual Product]
   714 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "parental cells in the presence of FBS"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   784   C0427850:Presence of cells [Laboratory or Test Result]
   762   C0439170:% fetal cells [Quantitative Concept]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in the culture medium,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "but"

Phrase: "not in parental cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0030551:Parental [Family Group]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of FBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "in the culture medium."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.163: Moreover, phosphorylated RB protein expression was also found in all five Id-1 transfectants (Figure 4D).  

Phrase: "Moreover,"

Phrase: "phosphorylated RB protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "found in all five Id-1 transfectants"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0150312:Found [Quantitative Concept]
   748   C0205451:Five [Quantitative Concept]
   748   C0600091:ID [Intellectual Product]
   714 E C0243095:Find [Finding]

Phrase: "(Figure"

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.164: Discussion Top Abstract Introduction Materials and methods Results Discussion References  In the present study, we first demonstrated that deregulation of Id-1 expression both at the mRNA and protein levels in human HCC, and level of immunohistologically detected protein correlated with levels of Id-1 mRNA. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In the present study,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that deregulation of Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880287:Deregulation [Activity]

Phrase: "both at the mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0238767:Both [Spatial Concept]
   760   C0335218:Messenger [Professional or Occupational Group]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "protein levels in human HCC,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "level of immunohistologically detected protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "correlated with levels of Id-1 mRNA."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0309276:ID-1 [Pharmacologic Substance]
   750   C0456947:Level 1 [Intellectual Product]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0335218:Messenger [Professional or Occupational Group]
   744   C0441889:Levels [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1707520:Correlated [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.165: Some reports have found the difference in Id-1 expression level between the mRNA level by RTPCR and protein level by western blot in ovarian cancer tissues and the discrepancy is due to strong expression of Id-1 in tumor vascular endothelia (19). 

Phrase: "Some reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the difference in Id-1 expression level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between the mRNA level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by RTPCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "protein level by western blot"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in ovarian cancer tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C1518744:Ovarian Tissue [Tissue]
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "and"

Phrase: "the discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "is due to strong expression of Id-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0309276:ID-1 [Pharmacologic Substance]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0442821:Strong [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C3146286:Due [Idea or Concept]

Phrase: "in tumor vascular endothelia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0014261:Endothelium, Vascular [Tissue]
   856 E C1706972:Blood Vessel Endothelium [Tissue]
   793   C0014257:Endothelium [Tissue]
   706   C0282607:tumor blood vessel [Neoplastic Process]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.166: From our immunostaining result, we observed nearly all cases showing positive vascular endothelia staining in both non-tumor and tumor tissue. 

Phrase: "From our immunostaining result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "nearly"

Phrase: "all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positive vascular endothelia staining in both non-tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]
   717   C0005835:blood staining [Body Substance]

Phrase: "and"

Phrase: "tumor tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0475358:Tumor tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.167: Some cases with absent Id-1 expression in tumor cells also show strong staining of Id-1 in tumor vascular endothelia. 

Phrase: "Some cases with absent Id-1 expression"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "in tumor cells also"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "strong staining of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "in tumor vascular endothelia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0014261:Endothelium, Vascular [Tissue]
   856 E C1706972:Blood Vessel Endothelium [Tissue]
   793   C0014257:Endothelium [Tissue]
   706   C0282607:tumor blood vessel [Neoplastic Process]
Processing 00000000.tx.168: This result is consistent with the previous finding that Id-1 is also strongly expressed in vascular smooth muscle cells (20). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with the previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   762   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "also strongly"

Phrase: "expressed in vascular smooth muscle cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.169: However, there is no significant increase in Id-1 expression in tumor vascular endothelia. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "no significant increase in Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in tumor vascular endothelia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0014261:Endothelium, Vascular [Tissue]
   856 E C1706972:Blood Vessel Endothelium [Tissue]
   793   C0014257:Endothelium [Tissue]
   706   C0282607:tumor blood vessel [Neoplastic Process]
Processing 00000000.tx.170: Evaluation of the whole patients' series revealed several significant associations with histopathological and other features of tumors. 

Phrase: "Evaluation of the whole patients' series"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0679830:evaluation patients [Health Care Activity]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "several significant associations with histopathological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "other features of tumors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.171: Of these, the correlation with mitotic index and p16INK4a were highly significant. 

Phrase: "Of these,"

Phrase: "the correlation with mitotic index"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "p16INK4a"

Phrase: "were"

Phrase: "highly significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1299395:Highly significant [Qualitative Concept]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.172: We found a positive and significant correlation between the protein expression of Id-1 and PCNA, which indirectly suggested the role of Id-1 in the proliferation of HCC cells. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "significant correlation between the protein expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "PCNA,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   861   C0069115:nuclear antigen [Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferating [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "which indirectly"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "of HCC cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
Processing 00000000.tx.173: This was further confirmed by our in vitro cell culture model. 

Phrase: "This"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by our in vitro cell culture model."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   793   C1515654:In Vitro Model [Research Activity]
   770   C0007585:Cell Culture [Laboratory Procedure]
   770   C0021135:In Vitro [Intellectual Product]
   770   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
   744   C0007634:Cell [Cell]
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0750484:Confirmed [Idea or Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3161035:Model [Intellectual Product]
   711 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.174: Increased PCNA expression in clone 3 with the highest ectopic Id-1 expression was also observed when compared with the control in the absence of FBS. 

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "PCNA expression in clone 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with the highest ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1512167:Ectopic Expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "compared with the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of FBS."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
Processing 00000000.tx.175: Our data further confirmed the function of Id-1 as a promoter of proliferation in cancers (2124). 

Phrase: "Our data further"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the function of Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "as a promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "in cancers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "(2124"

Phrase: ")."
Processing 00000000.tx.176: From the RTPCR result, it was also noted that Id-1 mRNA level in the non-tumor liver is relatively high when compared with the normal liver, but it was low when compared with the tumor tissue. 

Phrase: "From the RTPCR result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1274040:Result [Functional Concept]
   804   C1546471:Result [Idea or Concept]
   804   C2825142:Result [Finding]

Phrase: "it"

Phrase: "was"

Phrase: "also"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that Id-1 mRNA level in the non-tumor liver"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0456947:Level 1 [Intellectual Product]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1547707:Level [Geographic Area]
   738   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "relatively high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "compared with the normal liver,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0577059:normal liver [Finding]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]
   760   C2346688:LIVER [Food]
   760   C2347086:% Normal [Quantitative Concept]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "but"

Phrase: "it"

Phrase: "was"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "when"

Phrase: "compared with the tumor tissue."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0475358:Tumor tissue [Tissue]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1578706:Tumor [Intellectual Product]
   760   C1707455:Compared [Activity]
   760   C3273930:Tumor [Finding]
Processing 00000000.tx.177: Since most of our non-tumor cases are cirrhotic, which has a higher proliferative rate when compared with normal liver (25), it accounts for the enhanced Id-1 expression. 

Phrase: "Since"

Phrase: "most of our non-tumor cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205393:Most [Quantitative Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "cirrhotic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439686:Cirrhotic [Qualitative Concept]

Phrase: "which"

Phrase: "has"

Phrase: "a higher proliferative rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "when"

Phrase: "compared with normal liver"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0577059:normal liver [Finding]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1707455:Compared [Activity]
   770   C2346688:LIVER [Food]
   770   C2347086:% Normal [Quantitative Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "accounts for the enhanced Id-1 expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0600091:ID [Intellectual Product]
   748   C1551359:account [Idea or Concept]
   748   C2349975:Enhanced [Activity]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
Processing 00000000.tx.178: p16INK4a was found to be frequently inactivated in HCC through promoter methylation (16,2628). 

Phrase: "p16INK4a"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "inactivated in HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   833   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   770   C0007097:Carcinoma [Neoplastic Process]
   770   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "through promoter methylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0025723:Methylation [Molecular Function]
   861   C1159269:Methylation [Molecular Function]
   789 E C0746574:methylated [Pharmacologic Substance]

Phrase: "(16,"

Phrase: "2628"

Phrase: ")."
Processing 00000000.tx.179: However, few reports have demonstrated the direct transcriptional inactivation of p16INK4a in HCC. 

Phrase: "However,"

Phrase: "few reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the direct transcriptional inactivation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in HCC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]
Processing 00000000.tx.180: Since the transcriptional regulator Id-1 has recently been identified as a repressor of p16INK4a transcription (13,29,30), we sought to determine whether transcriptional inactivation of p16INK4a by Id-1 might play a role in the initiation and progression of HCC. 

Phrase: "Since"

Phrase: "the transcriptional regulator Id-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0309276:ID-1 [Pharmacologic Substance]
   812   C0040649:Transcriptional [Genetic Function]
   812   C0182953:REGULATOR [Medical Device]
   812   C0600091:ID [Intellectual Product]
   812   C1704734:Regulator [Medical Device]
   812   C1704735:Regulator [Conceptual Entity]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "identified as a repressor of p16INK4a transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1336789:Transcription Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor
   748   C0040649:Transcription [Genetic Function]
   748   C0205396:Identified [Qualitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "(13,"

Phrase: "29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "transcriptional inactivation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "by Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the initiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "progression of HCC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
Processing 00000000.tx.181: Recent reports showed that high level of Id-1 expression is correlated with the loss of p16INK4a in early stage melanoma (31), but is positively correlated with the expression of p16INK4a in breast cancer samples (32). 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that high level of Id-1 expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0456947:Level 1 [Intellectual Product]
   774   C3244092:expression level [Idea or Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1299351:High [Qualitative Concept]
   748   C1547707:Level [Geographic Area]
   748   C2700149:HIGH [Intellectual Product]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "correlated with the loss of p16INK4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517945:Loss [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "in early stage melanoma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0280209:stage melanoma [Neoplastic Process]
   827   C0025202:melanoma [Neoplastic Process]
   827   C2984289:Melanoma [Functional Concept]
   827   C3539018:Melanoma [Intellectual Product]
   734   C1517886:Early Stage [Classification]
   734   C2363430:Early stage [Temporal Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "is"

Phrase: "positively"

Phrase: "correlated with the expression of p16INK4a in breast cancer samples"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   793   C0006142:Cancer of the Breast [Neoplastic Process]
           Cancer of Breast
           Breast Cancer
   793   C0678222:Cancer of the Breast [Neoplastic Process]
           Cancer of Breast
           Breast Cancer
   741   C0586519:Breast sample [Body Substance]
   739   C0006141:Breast [Body Part, Organ, or Organ Component]
   739   C0006826:Cancer [Neoplastic Process]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0998265:Cancer [Eukaryote]
   739   C1268990:Breast [Body Part, Organ, or Organ Component]
   739   C1306459:Cancer [Finding]
   739   C1707520:Correlated [Qualitative Concept]
   710 E C0153661:thoracic cancer [Neoplastic Process]
   706   C0370003:Sample [Substance]
   706   C2347026:Sample [Conceptual Entity]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.182: In our study, we found that high Id-1 expression was significantly correlated with decreased p16INK4a expression and the result is similar to melanoma. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that high Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "correlated with decreased p16INK4a expression and"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "the result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "similar to melanoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.183: Hypermethylation of p16INK4a within the promoter was suggested to be one of the late events in hepatocarcinogenesis for tumor progression and metastases (33). 

Phrase: "Hypermethylation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512554:Hypermethylation [Genetic Function]

Phrase: "within the promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one of the late events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in hepatocarcinogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512409:Hepatocarcinogenesis [Neoplastic Process]

Phrase: "for tumor progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "metastases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027627:Metastases [Neoplastic Process]
  1000   C2939419:Metastases [Neoplastic Process]
   966 E C2939420:metastasis [Neoplastic Process]
   916 E C0036525:Metastatic [Functional Concept]
   916 E C1522484:metastatic [Quantitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.184: With reference to the hypothesis by Polsky et al. 

Phrase: "With reference to the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "by Polsky et al."
Processing 00000000.tx.185: (31), HCC hepatocarcinogenesis might also occur via multi-step that entails reversible Id-1 transcriptional inactivation of p16INK4a in the early growth phase that allows bypass of cellular senescence, and subsequent acquired epigenetic changes in cells such as promoter methylation for vertical growth phase for later stage. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "HCC hepatocarcinogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1512409:Hepatocarcinogenesis [Neoplastic Process]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "might"

Phrase: "also"

Phrase: "occur via multi-step"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439064:Multi [Quantitative Concept]
   770   C1261552:Step [Conceptual Entity]
   770   C1704379:Step [Functional Concept]
   770   C1705117:Step [Quantitative Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C2825408:Step [Manufactured Object]

Phrase: "that entails reversible Id-1 transcriptional inactivation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in the early growth phase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0018270:'growth' NOS [Organism Function]
   827   C0205390:Phase [Temporal Concept]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "bypass of cellular senescence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0741847:Bypass [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subsequent acquired epigenetic changes in cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1516924:Epigenetic Change [Genetic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "such as promoter methylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0025723:Methylation [Molecular Function]
   861   C1159269:Methylation [Molecular Function]
   789 E C0746574:methylated [Pharmacologic Substance]

Phrase: "for vertical growth phase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1336956:Vertical Growth Phase [Finding]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0205128:Vertical [Spatial Concept]
   827   C0205390:Phase [Temporal Concept]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "for later stage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1279941:Late stage [Temporal Concept]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.186: Further study on this subject is required. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "study on this subject"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0681850:Study Subject [Group]
           Subject
   770   C0557651:Study [Manufactured Object]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2603343:Study [Research Activity]
   770   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.187: Conclusively, these results suggested that inactivation of p16INK4a in HCC might be, in part, through transcription control of Id-1. 

Phrase: "Conclusively,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that inactivation of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in HCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "through transcription control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   964   C1158770:Transcriptional Control [Genetic Function]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of Id-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]
Processing 00000000.tx.188: In order to determine whether Id-1 plays a role in proliferation of HCC through inactivation of p16INK4a, we transfected PLC/PRF/5 by Id-1. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in proliferation of HCC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "through inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16INK4a,"

Phrase: "we"

Phrase: "transfected"

Phrase: "PLC/PRF/5 by Id-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0309276:ID-1 [Pharmacologic Substance]
   783   C1538187:PRF-1 [Gene or Genome]
   753   C0600091:ID [Intellectual Product]
Processing 00000000.tx.189: Five Id-1 transfectants were isolated and showed differential Id-1 expression. 

Phrase: "Five Id-1 transfectants"

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "differential Id-1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.190: All these five clones showed FBS-independent proliferation accompanied by increased PCNA expression and increased percentage of cell cycle S phase from G1 phase. 

Phrase: "All"

Phrase: "these five clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "FBS-independent proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0334094:Proliferation [Pathologic Function]
   804   C1514485:Proliferation [Functional Concept]

Phrase: "accompanied by increased PCNA expression and"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0072108:Proliferating Cell Nuclear Antigen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1366837:PROLIFERATING CELL NUCLEAR ANTIGEN [Gene or Genome]
   764   C0069115:nuclear antigen [Immunologic Factor]
   742   C0003320:Antigen [Immunologic Factor]
   742   C0007634:Cell [Cell]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0521447:Nuclear [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1514485:Proliferating [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "increased percentage of cell cycle S phase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "from G1 phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.191: Our in vitro results were consistent with the previous findings that ectopic Id-1 expression stimulated DNA synthesis from G1 to S phase (7,21,24,28) and resulted in down-regulation of p16INK4a in the Id-1 transfectants. 

Phrase: "Our in vitro results"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "were"

Phrase: "consistent with the previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "DNA synthesis from G1 to S phase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0598312:DNA Synthesis [Genetic Function]
   778   C1328870:DNA synthesis [Laboratory Procedure]
   778   C1817262:DNA synthesis [Genetic Function]
   774   C0080129:Synthesis Phase [Temporal Concept]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(7,"

Phrase: "21,"

Phrase: "24,"

Phrase: "28"

Phrase: ")"

Phrase: "and"

Phrase: "resulted in down-regulation of p16INK4a"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in the Id-1 transfectants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]
Processing 00000000.tx.192: This result further supported that p16INK4a inactivation was due to transcription control of Id-1. 

Phrase: "This result further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "that p16INK4a inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "was due to transcription control of Id-1."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0309276:ID-1 [Pharmacologic Substance]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0040649:Transcription [Genetic Function]
   744   C0043194:WAS [Disease or Syndrome]
   744   C0243148:control [Qualitative Concept]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0600091:ID [Intellectual Product]
   744   C1421478:WAS [Gene or Genome]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3146286:Due [Idea or Concept]
   744   C3274648:Control [Qualitative Concept]
   735   C1158770:Transcriptional Control [Genetic Function]
Processing 00000000.tx.193: Other than p16INK4a, ectopic Id-1 expression induced RB phosphorylation in human keratinocytes (28). 

Phrase: "Other than p16INK4a,"

Phrase: "ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "RB phosphorylation in human keratinocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.194: One of the functions of p16INK4a is to prevent cyclin-dependent kinases such as CDK4 and results in prevention of RB phosphorylation. 

Phrase: "One of the functions of p16INK4a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "cyclin-dependent kinases such as CDK4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   855   C0246957:Cdk4 Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0243045:Cyclin-Dependent Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1150565:cyclin [Molecular Function]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "results in prevention of RB phosphorylation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0035335:Retinoblastoma [Neoplastic Process]
   753   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0199176:Prevention [Therapeutic or Preventive Procedure]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1706420:PREVENTION [Research Activity]
   753   C2700409:prevention [Qualitative Concept]
   753   C2825142:Result [Finding]
   753   C3540616:Retinoblastoma [Intellectual Product]
Processing 00000000.tx.195: In our study, we found that increased expression of phosphorylated CDK4 and RB was only observed in the five Id-1 transfectants but not in the control. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that increased expression of phosphorylated CDK4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "RB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in the five Id-1 transfectants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0205451:Five [Quantitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1441672:Observed [Functional Concept]

Phrase: "but"

Phrase: "not in the control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.196: This showed that down-regulation of p16INK4a was associated with increased expression of phosphorylated CDK4 and RB but not with CDK and RB levels. 

Phrase: "This"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that down-regulation of p16INK4a"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "was"

Phrase: "associated with increased expression of phosphorylated CDK4"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "RB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "but"

Phrase: "not with CDK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1150557:CDK [Molecular Function]
   790   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "RB levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.197: RB phosphorylation is proposed to regulate cell cycle regulation from G1 to S phase through cyclin D and CDK4/6 complex. 

Phrase: "RB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "cell cycle regulation from G1 to S phase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1155872:Cell Cycle Regulation [Cell Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "through cyclin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0388730:Cyclin D [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "CDK4/6 complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.198: Without the inhibition of p16INK4a, CDK4 becomes phosphorylated and can prevent the binding of E2F with RB, resulting in G1 to S phase conversion by RB phosphorylation (34). 

Phrase: "Without the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of p16INK4a,"

Phrase: "CDK4"

Phrase: "becomes"

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the binding of E2F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "with RB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "resulting in G1 to S phase conversion"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0080129:S Phase [Temporal Concept]
   778   C0332294:Resulting in [Functional Concept]
   774   C0079395:G1 Phase [Temporal Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C0439836:Conversion [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "by RB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.199: In our study, all Id-1 transfectants showed a variable degree of G1 to S phase conversion. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "all Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a variable degree of G1 to S phase conversion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0441889:Degree [Qualitative Concept]
   742   C0449286:Degree [Quantitative Concept]
   742   C0542560:Degree [Intellectual Product]
   742   C1561545:degree [Quantitative Concept]
   742   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.200: Therefore, these results suggested that the effect of Id-1 on proliferation on HCC cells might be caused by the decreased p16INK4a, which in turn inactivated RB. 

Phrase: "Therefore,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "on HCC cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1512411:Hepatocellular carcinoma [Neoplastic Process]
   734   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]

Phrase: "might"

Phrase: "be"

Phrase: "caused by the decreased p16INK4a,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726   C0015127:cause [Functional Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "which in turn inactivated RB."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035335:Retinoblastoma [Neoplastic Process]
   812   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C3540616:Retinoblastoma [Intellectual Product]
Processing 00000000.tx.201: In summary, our in vitro and in vivo data provided evidence for the first time on over-expression of Id-1 and its role in HCC. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "evidence for the first time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "on over-expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0205136:Over [Spatial Concept]

Phrase: "of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "and"

Phrase: "its role in HCC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.202: Over-expression of Id-1 played a role in HCC cell proliferation. 

Phrase: "Over-expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "played"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600138:played [Finding]
   966 E C0032214:Play [Daily or Recreational Activity]

Phrase: "a role in HCC cell proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.203: Id-1 induced HCC proliferation through inactivation of p16INK4a/pRB pathway as shown by the evidence of decreased p16INK4a expression and activation of CDK and RB in the five Id-1 transfectants. 

Phrase: "Id-1 induced HCC proliferation through inactivation of p16INK4a/pRB pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0334094:Proliferation [Pathologic Function]
   736   C1514485:Proliferation [Functional Concept]

Phrase: "as"

Phrase: "shown by the evidence of decreased p16INK4a expression and"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0332120:Evidence of [Functional Concept]
           Evidence
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   708 E C0547047:Decrease [Quantitative Concept]
   708   C1547282:Show [Intellectual Product]

Phrase: "activation of CDK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "RB in the five Id-1 transfectants."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0694889:retinoblastoma 1 [Gene or Genome]
   748   C0035335:Retinoblastoma [Neoplastic Process]
   748   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3540616:Retinoblastoma [Intellectual Product]
Processing 00000000.tx.204: Our results provided an insight for the understanding of the role of Id-1 in functional inactivation of p16INK4a in HCC.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "an insight for the understanding of the role of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0233820:Insight [Mental Process]

Phrase: "in functional inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16INK4a"

Phrase: "in HCC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]
Processing 00000000.tx.205: Notes  4 To whom correspondence should be addressed Email: hrmsfst{at}hkucc.hku.hk  References Top Abstract Introduction Materials and methods Results Discussion References  Norton,J.D., Deed,R.W., Craggs,G. and Sablitzky,F. 

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "4 To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hrmsfst{at}hkucc.hku.hk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0019907:HK [Geographic Area]
   804   C2681927:HK [Gene or Genome]
   804   C2987742:HK [Fish]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Norton,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Deed,"

Phrase: "R.W., Craggs,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sablitzky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.206: (1998) Id helix loophelix proteins in cell growth and differentiation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Id helix loophelix proteins in cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0007595:Cell Growth [Cell Function]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.207: Trends Cell Biol., 8, 5865.[CrossRef][ISI][Medline] Norton,J.D. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol.,"

Phrase: "8,"

Phrase: "5865."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Norton,"

Phrase: "J.D."
Processing 00000000.tx.208: (2000) ID helixloophelix proteins in cell growth, differentiation and tumorigenesis. 

Phrase: "(2000"

Phrase: ")"

Phrase: "ID helixloophelix proteins in cell growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007595:Cell Growth [Cell Function]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2911660:Growth [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "tumorigenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007621:Tumorigenesis [Neoplastic Process]
  1000   C0596263:Tumorigenesis [Neoplastic Process]
Processing 00000000.tx.209: J. 

Phrase: "J."
Processing 00000000.tx.210: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.211: Sci., 113, 38973905.[Abstract/Free FullText] Israel,M.A., Hernandez,M.C., Florio,M., Andres-Barquin,P.J., Mantani,A., Carter,J.H. and Julin,C.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "113,"

Phrase: "38973905."

Phrase: "[Abstract/Free FullText"

Phrase: "] Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hernandez,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Florio,"

Phrase: "M."

Phrase: ","

Phrase: "Andres-Barquin,"

Phrase: "P.J.,"

Phrase: "Mantani,"

Phrase: "A.,"

Phrase: "Carter,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Julin,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.212: (1999) Id gene expression as a key mediator of tumor cell biology. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Id gene expression as a key mediator of tumor cell biology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0017262:Gene Expression [Genetic Function]
   754   C1706509:Gene ID [Intellectual Product]
   754   C1861886:CELL Gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.213: Cancer Res., 59 (7 suppl.), 17261730. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "59"

Phrase: "(7 suppl."

Phrase: ")"

Phrase: ","

Phrase: "17261730."
Processing 00000000.tx.214: Lundberg,A.S., Hahn,W.C., Gupta,P. and Weinberg,R.A. 

Phrase: "Lundberg,"

Phrase: "A.S.,"

Phrase: "Hahn,"

Phrase: "W.C., Gupta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Weinberg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.215: (2000) Genes involved in senescence and immortalization. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in senescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231337:Senescence [Finding]
   790   C1314939:Involved [Functional Concept]
   790   C1999167:Senescence [Population Group]

Phrase: "and"

Phrase: "immortalization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826170:Immortalization [Molecular Biology Research Technique]
Processing 00000000.tx.216: Curr. 

Phrase: "Curr."
Processing 00000000.tx.217: Opin. 

Phrase: "Opin."
Processing 00000000.tx.218: Cell Biol., 12, 705709.[CrossRef][ISI][Medline] Hahn,W.C., Counter,C.M., Lundberg,A.S., Beijersbergen,R.L., Brooks,M.W. and Weinberg,R.A. 

Phrase: "Cell Biol.,"

Phrase: "12,"

Phrase: "705709."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hahn,"

Phrase: "W.C., Counter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0677601:Counter [Manufactured Object]
   827   C1705206:Counter [Medical Device]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Lundberg,"

Phrase: "A.S.,"

Phrase: "Beijersbergen,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brooks,"

Phrase: "M."

Phrase: "W."

Phrase: "and"

Phrase: "Weinberg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.219: (1999) Creation of human tumour cells with defined genetic elements. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Creation of human tumour cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441513:Creation [Therapeutic or Preventive Procedure]
   760   C1706214:Creation [Activity]

Phrase: "with defined genetic elements."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0599770:genetic element [Gene or Genome]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.220: Nature, 400, 464468.[CrossRef][ISI][Medline] Kiyono,T., Foster,S.A., Koop,J.I., McDougall,J.K., Galloway,D.A. and Klingelhutz,A.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "400,"

Phrase: "464468."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kiyono,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Koop,"

Phrase: "J.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "McDougall,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Galloway,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Klingelhutz,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.221: (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Both Rb/p16INK4a inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "telomerase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1148756:telomerase activity [Genetic Function]
   861   C0087071:Telomerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "immortalize"

Phrase: "human epithelial cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.222: Nature, 396, 8488.[CrossRef][ISI][Medline] Lin,C.Q., Singh,J., Murata,K., Itahana,Y., Parrinello,S., Liang,S.H., Gillett,C.E., Campisi,J. and Desprez,P.Y. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "396,"

Phrase: "8488."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin,C.Q., Singh,"

Phrase: "J.,"

Phrase: "Murata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Itahana,"

Phrase: "Y.,"

Phrase: "Parrinello,"

Phrase: "S."

Phrase: ","

Phrase: "Liang,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gillett,"

Phrase: "C.E.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C1553033:[c] [Quantitative Concept]

Phrase: "Campisi,"

Phrase: "J."

Phrase: "and"

Phrase: "Desprez,"

Phrase: "P.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.223: (2000) A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A role for Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the aggressive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "steroid hormone response of human breast cancer cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.224: Cancer Res., 60, 13321340.[Abstract/Free FullText] Kleeff,J., Ishiwata,T., Friess,H., Buchler,M.W., Israel,M.A. and Korc,M. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "13321340."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kleeff,"

Phrase: "J.,"

Phrase: "Ishiwata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Friess,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Buchler,"

Phrase: "M."

Phrase: "W., Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022271:Israel [Geographic Area]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Korc,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.225: (1998) The helixloophelix protein Id2 is overexpressed in human pancreatic cancer. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The helixloophelix protein Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1334077:ID2 [Gene or Genome]

Phrase: "is"

Phrase: "overexpressed in human pancreatic cancer."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0235974:PANCREATIC CANCER [Neoplastic Process]
   806   C0346647:Pancreatic Cancer [Neoplastic Process]
   806   C2984259:Pancreatic cancer [Functional Concept]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0998265:Cancer [Eukaryote]
   760   C1306459:Cancer [Finding]
   726   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.226: Cancer Res., 58, 37693772.[Abstract] Ouyang,X.S., Wang,X., Lee,D.T., Tsao,S.W. and Wong,Y.C. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "58,"

Phrase: "37693772."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ouyang,"

Phrase: "X.S.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Lee,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.227: (2002) Over expression of ID-1 in prostate cancer. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Over expression of ID-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "in prostate cancer."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.228: J. 

Phrase: "J."
Processing 00000000.tx.229: Urol., 167, 25982602.[ISI][Medline] Schindl,M., Oberhuber,G., Obermair,A., Schoppmann,S.F., Karner,B. and Birner,P. 

Phrase: "Urol.,"

Phrase: "167,"

Phrase: "25982602."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Oberhuber,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Obermair,"

Phrase: "A.,"

Phrase: "Schoppmann,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Karner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.230: (2001) Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Overexpression of Id-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "is"

Phrase: "a marker for unfavorable prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514475:Prognosis Marker [Qualitative Concept]
   760   C0005516:Marker [Clinical Attribute]

Phrase: "in early-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "cervical cancer."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007847:Cervical Cancer [Neoplastic Process]
  1000   C0302592:Cervical Cancer [Neoplastic Process]
  1000   C3539064:Cervical Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0027530:Cervical [Body Location or Region]
   861   C0205064:Cervical [Spatial Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.231: Cancer Res., 61, 57035706.[Abstract/Free FullText] Wilson,J.W., Deed,R.W., Inoue,T., Balzi,M., Becciolini,A., Faraoni,P., Potten,C.S. and Norton,J.D. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "61,"

Phrase: "57035706."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilson,"

Phrase: "J.W., Deed,"

Phrase: "R.W., Inoue,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Balzi,"

Phrase: "M."

Phrase: ","

Phrase: "Becciolini,"

Phrase: "A.,"

Phrase: "Faraoni,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Potten,"

Phrase: "C.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Norton,"

Phrase: "J.D."
Processing 00000000.tx.232: (2001) Expression of Id helixloophelix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Expression of Id helixloophelix proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in colorectal adenocarcinoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1319315:Colorectal Adenocarcinoma [Neoplastic Process]
   861   C0001418:Adenocarcinoma [Neoplastic Process]

Phrase: "correlates with p53 expression and"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079419:P53 [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1705526:p53 [Gene or Genome]

Phrase: "mitotic index."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812425:Mitotic Index [Laboratory or Test Result]
   861   C0918012:Index [Intellectual Product]
   861   C1513354:Mitotic [Qualitative Concept]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.233: Cancer Res., 61, 88038810.[Abstract/Free FullText] Langlands,K., Down,G.A. and Kealey,T. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "61,"

Phrase: "88038810."

Phrase: "[Abstract/Free FullText"

Phrase: "] Langlands,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Down,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."

Phrase: "and"

Phrase: "Kealey,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.234: (2000) Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "dynamically"

Phrase: "expressed in normal epidermis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0014520:Epidermis [Tissue]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3496194:Epidermis [Cell]

Phrase: "and"

Phrase: "dysregulated in squamous cell carcinoma."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0007137:Squamous cell carcinoma [Neoplastic Process]
           Carcinoma, Squamous
   806   C0221910:Squamous cell [Cell]
   797   C1518174:Carcinoma Cell [Cell]
   760   C0007097:Carcinoma [Neoplastic Process]
   760   C0007634:Cell [Cell]
   760   C1182670:Squamous [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.235: Cancer Res., 60, 59295933.[Abstract/Free FullText] Ohtani,N., Zebedee,Z., Huot,T.J., Stinson,J.A., Sugimoto,M., Ohashi,Y., Sharrocks,A.D., Peters,G. and Hara,E. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "59295933."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohtani,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Zebedee,"

Phrase: "Z.,"

Phrase: "Huot,"

Phrase: "T.J.,"

Phrase: "Stinson,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Sugimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Ohashi,"

Phrase: "Y.,"

Phrase: "Sharrocks,"

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Peters,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "E."
Processing 00000000.tx.236: (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Opposing effects of Ets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Id proteins on p16INK4a expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0249880:p16INK4A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1171362:expression protein [Genetic Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during cellular senescence."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007581:Senescence, Cellular [Cell Function]
   861   C0231337:Senescence [Finding]
   861   C1999167:Senescence [Population Group]
Processing 00000000.tx.237: Nature, 409, 10671070.[CrossRef][ISI][Medline] Sherr,C.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "409,"

Phrase: "10671070."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherr,"

Phrase: "C.J."
Processing 00000000.tx.238: (1996) Cancer cell cycles. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cancer cell cycles."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0007586:Cycles, Cell [Cell Function]
   867 E C1155839:Cell Cycle [Cell Function]
   793   C1511572:Cycle [Temporal Concept]
   734   C0334227:Cancer Cell [Cell]
Processing 00000000.tx.239: Science, 274, 16721677.[Abstract/Free FullText] Jin,M., Piao,Z., Kim,N.G., Park,C., Shin,E.C., Park,J.H., Jung,H.J., Kim,C.G. and Kim,M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "274,"

Phrase: "16721677."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jin,"

Phrase: "M."

Phrase: ","

Phrase: "Piao,"

Phrase: "Z.,"

Phrase: "Kim,"

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "E."

Phrase: "C., Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0562547:Park [Manufactured Object]
   861   C3160718:PARK [Disease or Syndrome]

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jung,"

Phrase: "H.J.,"

Phrase: "Kim,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.240: (2000) p16 is a major inactivation target in hepatocellular carcinoma. 

Phrase: "(2000"

Phrase: ")"

Phrase: "p16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525037:p16 [Gene or Genome]

Phrase: "is"

Phrase: "a major inactivation target in hepatocellular carcinoma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1521840:Target [Functional Concept]
   748   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.241: Cancer, 89, 6068.[CrossRef][ISI][Medline] Tannapfel,A., Busse,C., Weinans,L., Benicke,M., Katalinic,A., Geissler,F., Hauss,J. and Wittekind,C. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "89,"

Phrase: "6068."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tannapfel,"

Phrase: "A.,"

Phrase: "Busse,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Weinans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Benicke,"

Phrase: "M."

Phrase: ","

Phrase: "Katalinic,"

Phrase: "A.,"

Phrase: "Geissler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hauss,"

Phrase: "J."

Phrase: "and"

Phrase: "Wittekind,"

Phrase: "C."
Processing 00000000.tx.242: (2001) INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. 

Phrase: "(2001"

Phrase: ")"

Phrase: "INK4a-ARF alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "p53 mutations in hepatocellular carcinomas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.243: Oncogene, 20, 71047109.[CrossRef][ISI][Medline] Dynlacht,B.D. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "20,"

Phrase: "71047109."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dynlacht,"

Phrase: "B.D."
Processing 00000000.tx.244: (1997) Regulation of transcription by proteins that control the cell cycle. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Regulation of transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1158770:Transcription Regulation [Genetic Function]
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "by proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.245: Nature, 389, 149152.[CrossRef][ISI][Medline] Birner,P., Schindl,M., Obermair,A., Plank,C., Breitenecker,G. and Oberhuber,G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "389,"

Phrase: "149152."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Birner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Obermair,"

Phrase: "A.,"

Phrase: "Plank,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Breitenecker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Oberhuber,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.246: (2000) Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Overexpression of hypoxia-inducible factor 1alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "a marker for an unfavorable prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514475:Prognosis Marker [Qualitative Concept]
   753   C0005516:Marker [Clinical Attribute]

Phrase: "in early-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "invasive cervical cancer."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1334177:invasive cervical cancer [Neoplastic Process]
   913   C0677898:invasive cancer [Neoplastic Process]
   901   C0007847:Cervical Cancer [Neoplastic Process]
   901   C0302592:Cervical Cancer [Neoplastic Process]
   901   C3539064:Cervical Cancer [Intellectual Product]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0027530:Cervical [Body Location or Region]
   827   C0205064:Cervical [Spatial Concept]
   827   C0205281:Invasive [Qualitative Concept]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.247: Cancer Res., 60, 46934696.[Abstract/Free FullText] Schindl,M., Schoppmann,S.F., Strobel,T., Heinzl,H., Leisser,C., Horvat,R. and Birner,P. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "46934696."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Schoppmann,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Strobel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Heinzl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leisser,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Horvat,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.248: (2003) Level of id-1 protein expression correlates with poor differentiation, enhanced malignant potential and more aggressive clinical behavior of epithelial ovarian tumors. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Level of id-1 protein expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0428479:Protein level [Laboratory or Test Result]
   783   C0456947:Level 1 [Intellectual Product]
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "correlates with poor differentiation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007589:Differentiation [Cell Function]
   770   C0032854:Poor [Group Attribute]
   770   C0542537:Poor [Qualitative Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2700379:Poor [Qualitative Concept]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "malignant potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "more aggressive clinical behavior of epithelial ovarian tumors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C0475436:Behavior of tumor [Functional Concept]
   767   C0001807:Aggressive behavior [Mental or Behavioral Dysfunction]
   744   C0004927:Behavior [Individual Behavior]
   744   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.249: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.250: Cancer Res., 9, 779785.[Abstract/Free FullText] Uehara,N., Chou,Y.C., Galvez,J.J., de-Candia,P., Cardiff,R.D., Benezra,R. and Shyamala,G. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "9,"

Phrase: "779785."

Phrase: "[Abstract/Free FullText"

Phrase: "] Uehara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Chou,"

Phrase: "Y.C., Galvez,"

Phrase: "J.J.,"

Phrase: "de-Candia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cardiff,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Benezra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Shyamala,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.251: (2003) Id-1 is not expressed in the luminal epithelial cells of mammary glands. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed in the luminal epithelial cells of mammary glands."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0014597:Epithelial Cells [Cell]
   764   C0929301:Mammary Glands [Body Part, Organ, or Organ Component]
           Mammary
   764   C1273342:Epithelial Cells [Laboratory Procedure]
   742   C0006141:Mammary [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0221908:Epithelial [Qualitative Concept]
   742   C0524462:Luminal [Spatial Concept]
   742   C1285092:Glands [Body Part, Organ, or Organ Component]
   742   C3282337:Cells [Cell]
   731 E C1521747:GLAND, MAMMARY [Tissue]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: Breast Cancer Res., 2, R25R29. 

Phrase: "Breast Cancer Res.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2347379:RES [Finding]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "R25R29."
Processing 00000000.tx.253: Ouyang,X.S., Wang,X., Ling,M.T., Wong,H.L., Tsao,S.W. and Wong,Y.C. 

Phrase: "Ouyang,"

Phrase: "X.S.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wong,"

Phrase: "H.L., Tsao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.254: (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16 (INK4a)/pRB pathway. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "stimulates"

Phrase: "serum independent prostate cancer cell proliferation through inactivation of p16"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0334227:Cancer Cell [Cell]
   760   C0596290:Cell Proliferation [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0334094:Proliferation [Pathologic Function]
   739   C1269647:Cell [Cell]
   739   C1514485:Proliferation [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "(INK4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0525037:INK4a [Gene or Genome]
  1000   C1705280:INK4A [Gene or Genome]

Phrase: ")"

Phrase: "/pRB pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.255: Carcinogenesis, 23, 721725.[Abstract/Free FullText] Wice,B.M. and Gordon,J.I. 

Phrase: "Carcinogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "721725."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wice,"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gordon,"

Phrase: "J.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.256: (1998) Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Forced expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the adult mouse small intestinal epithelium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0227263:Small intestinal epithelium [Body Part, Organ, or Organ Component]
   875   C0440438:Mouse epithelium [Body Substance]
   840   C0226890:Intestinal Epithelium [Tissue]
   840   C1280750:Intestinal epithelium [Tissue]
   804   C0014609:Epithelium [Tissue]
   733 E C0221908:Epithelial [Qualitative Concept]

Phrase: "is"

Phrase: "associated with development of adenomas."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0001430:Adenomas [Neoplastic Process]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.257: J. 

Phrase: "J."
Processing 00000000.tx.258: Biol. 

Phrase: "Biol."
Processing 00000000.tx.259: Chem., 273, 2531025319.[Abstract/Free FullText] Alani,R.M., Hasskarl,J., Grace,M., Hernandez,M.C., Israel,M.A. and Munger,K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "2531025319."

Phrase: "[Abstract/Free FullText"

Phrase: "] Alani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Hasskarl,"

Phrase: "J.,"

Phrase: "Grace,"

Phrase: "M."

Phrase: ","

Phrase: "Hernandez,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Munger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.260: (1999) Immortalization of primary human keratinocytes by the helixloophelix protein, Id-1. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immortalization of primary human keratinocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2826170:Immortalization [Molecular Biology Research Technique]

Phrase: "by the helixloophelix protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Id-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]
Processing 00000000.tx.261: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.262: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.263: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.264: USA, 96, 96379641.[Abstract/Free FullText] Hara,E., Yamaguchi,T., Nojima,H., Ide,T., Campisi,J., Okayama,H. and Oda,K. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "96379641."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Yamaguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nojima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ide,T.,"

Phrase: "Campisi,"

Phrase: "J.,"

Phrase: "Okayama,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Oda,K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.265: (1994) Id-related genes encoding helixloophelix proteins are required for G1 progression and are repressed in senescent human fibroblasts. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Id-related genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "helixloophelix proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "required for G1 progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "repressed in senescent human fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016030:Fibroblasts [Cell]
   760   C0086418:Human [Human]
Processing 00000000.tx.266: J. 

Phrase: "J."
Processing 00000000.tx.267: Biol. 

Phrase: "Biol."
Processing 00000000.tx.268: Chem., 269, 21392145.[Abstract/Free FullText] Donato,M.F., Arosio,E., Del Ninno,E., Ronchi,G., Lampertico,P., Morabito,A., Balestrieri,M.R. and Colombo,M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "21392145."

Phrase: "[Abstract/Free FullText"

Phrase: "] Donato,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Arosio,"

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Del Ninno,"

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Ronchi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lampertico,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Morabito,"

Phrase: "A.,"

Phrase: "Balestrieri,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Colombo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.269: (2001) High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. 

Phrase: "(2001"

Phrase: ")"

Phrase: "High rates of hepatocellular carcinoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in cirrhotic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with high liver cell proliferative activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0812425:Cell Proliferative Activity [Laboratory or Test Result]
   804   C0205177:Activity [Functional Concept]
   804   C0334094:Proliferative [Pathologic Function]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.270: Hepatology, 34, 523528.[CrossRef][ISI][Medline] Azechi,H., Nishida,N., Fukuda,Y. et al. 

Phrase: "Hepatology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086403:Hepatology [Biomedical Occupation or Discipline]
  1000   C1555763:Hepatology [Professional or Occupational Group]

Phrase: "34,"

Phrase: "523528."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Azechi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nishida,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fukuda,"

Phrase: "Y. et al."
Processing 00000000.tx.271: (2001) Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Disruption of the p16/cyclin D1/retinoblastoma protein pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: "in the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of human hepatocellular carcinomas."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C2239176:Hepatocellular Carcinomas [Neoplastic Process]
   884 E C1512411:Hepatocellular carcinoma [Neoplastic Process]
   827   C0007097:Carcinomas [Neoplastic Process]
Processing 00000000.tx.272: Oncology, 60, 346354.[CrossRef][ISI][Medline] Saito,Y., Kanai,Y., Sakamoto,M., Saito,H., Ishii,H. and Hirohashi,S. 

Phrase: "Oncology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0278627:Oncology [Biomedical Occupation or Discipline]
   928 E C0205478:Oncologic [Biomedical Occupation or Discipline]

Phrase: "60,"

Phrase: "346354."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Saito,"

Phrase: "Y.,"

Phrase: "Kanai,"

Phrase: "Y.,"

Phrase: "Sakamoto,"

Phrase: "M."

Phrase: ","

Phrase: "Saito,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ishii,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hirohashi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.273: (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Expression of mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0040649:RNA Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for DNA methyltransferases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0012873:DNA Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1414121:DNA METHYLTRANSFERASE [Gene or Genome]
   966   C1511681:DNA Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0025831:Methyltransferases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "methyl-CpG-binding proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1148748:methyl-CpG binding [Genetic Function]
   906   C1428372:CpG-BINDING PROTEIN [Gene or Genome]
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "DNA methylation status on CpG islands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "pericentromeric satellite regions during human hepatocarcinogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]
Processing 00000000.tx.274: Hepatology, 33, 561568.[CrossRef][ISI][Medline] Alani,R.M., Young,A.Z. and Shifflett,C.B. 

Phrase: "Hepatology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086403:Hepatology [Biomedical Occupation or Discipline]
  1000   C1555763:Hepatology [Professional or Occupational Group]

Phrase: "33,"

Phrase: "561568."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A.Z."

Phrase: "and"

Phrase: "Shifflett,"

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.275: (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Id1 regulation of cellular senescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   926   C3270399:regulation of cellular senescence [Biologic Function]
   797   C0596286:Cellular Regulation [Cell Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "through transcriptional repression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0920533:Transcriptional Repression [Genetic Function]
   861   C0035143:Repression [Mental Process]

Phrase: "of p16/Ink4a."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0249880:p16-INK4a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0525037:INK4a [Gene or Genome]
   861   C1705280:INK4A [Gene or Genome]
Processing 00000000.tx.276: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.277: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.278: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.279: USA, 98, 78127816.[Abstract/Free FullText] Pagliuca,A., Gallo,P., De, Luca,P. and Lania,L. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "98,"

Phrase: "78127816."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pagliuca,"

Phrase: "A.,"

Phrase: "Gallo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "Luca,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lania,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.280: (2000) Class A helixloophelix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A helixloophelix proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "positive regulators of several cyclin-dependent kinase inhibitors' promoter activity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C1152602:kinase regulator activity [Molecular Function]
   739   C0182953:regulators [Medical Device]
   706 E C1704734:Regulator [Medical Device]
   706 E C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "negatively"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell growth."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.281: Cancer Res., 60, 13761382.[ISI][Medline] Peverali,F.A., Ramqvist,T., Saffrich,R., Pepperkok,R., Barone,M.V. and Philipson,L. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "13761382."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Peverali,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Ramqvist,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Saffrich,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pepperkok,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Barone,"

Phrase: "M."

Phrase: "V."

Phrase: "and"

Phrase: "Philipson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.282: (1994) Regulation of G1 progression by E2A and Id helixloophelix proteins. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Regulation of G1 progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by E2A"

Phrase: "and"

Phrase: "Id helixloophelix proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.283: EMBO J., 13, 42914301.[Abstract] Polsky,D., Young,A.Z., Busam,K.J. and Alani,R.M. 

Phrase: "EMBO J.,"

Phrase: "13,"

Phrase: "42914301."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Polsky,"

Phrase: "D."

Phrase: ","

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A.Z.,"

Phrase: "Busam,"

Phrase: "K.J."

Phrase: "and"

Phrase: "Alani,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.284: (2001) The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The transcriptional repressor of p16/Ink4a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor

Phrase: "Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "is"

Phrase: "up-regulated in early melanomas."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025202:Melanomas [Neoplastic Process]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1279919:Early [Temporal Concept]
   760   C1282911:Up [Spatial Concept]
   726 E C2984289:Melanoma [Functional Concept]
   726 E C3539018:Melanoma [Intellectual Product]
Processing 00000000.tx.285: Cancer Res., 61, 60086011.[Abstract/Free FullText] Schoppmann,S,F., Schindl,M., Bayer,G., Aumayr,K., Dienes,J., Horvat,R., Rudas,M., Gnant,M., Jakesz,R. and Birner,P. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "61,"

Phrase: "60086011."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schoppmann,"

Phrase: "S,F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Bayer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aumayr,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dienes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596439:dienes [Organic Chemical]

Phrase: "J.,"

Phrase: "Horvat,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rudas,"

Phrase: "M."

Phrase: ","

Phrase: "Gnant,"

Phrase: "M."

Phrase: ","

Phrase: "Jakesz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.286: (2003) Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "associated with poor clinical outcome"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032854:Poor [Group Attribute]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0542537:Poor [Qualitative Concept]
   760   C1274040:Outcome [Functional Concept]
   760   C2700379:Poor [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in node negative breast cancer."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0006142:Breast Cancer [Neoplastic Process]
   861   C0678222:Breast Cancer [Neoplastic Process]
   812   C0006141:Breast [Body Part, Organ, or Organ Component]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1268990:Breast [Body Part, Organ, or Organ Component]
   812   C1306459:Cancer [Finding]
   811 E C0153661:thoracic cancer [Neoplastic Process]
   756 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   756 E C1521735:Pectoral [Qualitative Concept]
   729 E C0817096:Chest [Body Location or Region]
   729 E C1527391:Chest [Body Location or Region]
Processing 00000000.tx.287: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.288: J. 

Phrase: "J."
Processing 00000000.tx.289: Cancer, 104, 677682.[CrossRef][ISI][Medline] Feitelson,M.A., Sun,B., Satiroglu Tufan,N.L., Liu,J., Pan,J. and Lian,Z. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "104,"

Phrase: "677682."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Feitelson,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Satiroglu Tufan,"

Phrase: "N.L., Liu,"

Phrase: "J.,"

Phrase: "Pan,J."

Phrase: "and"

Phrase: "Lian,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330941:lian [Plant]

Phrase: "Z."
Processing 00000000.tx.290: (2002) Genetic mechanisms of hepatocarcinogenesis. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genetic mechanisms of hepatocarcinogenesis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.291: Oncogene, 21, 25932604.[CrossRef][ISI][Medline] Kato,J., Matsushime,H., Hiebert,S.W., Ewen,M.E. and Sherr,C.J. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "21,"

Phrase: "25932604."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "J.,"

Phrase: "Matsushime,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hiebert,"

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ewen,"

Phrase: "M."

Phrase: "E."

Phrase: "and"

Phrase: "Sherr,"

Phrase: "C.J."
Processing 00000000.tx.292: (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "binding of cyclin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149168:cyclin binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the retinoblastoma gene product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0079424:Retinoblastoma Gene [Gene or Genome]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "(pRb)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080113:pRb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "pRb phosphorylation by the cyclin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "D-"

Phrase: "dependent kinase CDK4."
Processing 00000000.tx.293: Genes Dev., 7, 331342.[Abstract] Received April 25, 2003; 

Phrase: "Genes Dev.,"

Phrase: "7,"

Phrase: "331342."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Received April 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.294: revised July 27, 2003; 

Phrase: "revised July 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.295: accepted August 4, 2003. 

Phrase: "accepted August 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.296: This Article Abstract FREE Full Text (PDF) All Versions of this Article: 24/11/1729 most recent bgg145v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (7) Request Permissions Google Scholar Articles by Lee, T. 

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "24/11/1729 most recent bgg145v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(7"

Phrase: ")"

Phrase: "Request Permissions Google Scholar Articles by Lee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: K.-W. 

Phrase: "K.-W."
Processing 00000000.tx.298: Articles by Fan, S.-T. 

Phrase: "Articles by Fan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "S.-"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.299: PubMed PubMed Citation Articles by Lee, T. 

Phrase: "PubMed PubMed Citation Articles by Lee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.300: K.-W. 

Phrase: "K.-W."
Processing 00000000.tx.301: Articles by Fan, S.-T. 

Phrase: "Articles by Fan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "S.-"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.302: Online ISSN 1460-2180 - Print ISSN 0143-3334 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2180 - Print ISSN 0143-3334 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

